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UNDERSTANDING THE MECHANISM OF GENOMIC INSTABILITY
DURING REPLICATIVE AGING IN BUDDING YEAST

Sangita Pal, M.S.

Advisory Professor: Jessica K. Tyler, Ph.D.

Aging brings a gradual decline in molecular fidelity and biological
functionality, resulting in age related phenotypes and diseases. Despite
continued efforts to uncover the conserved aging pathways among eukaryotes,
exact molecular causes of aging are still poorly understood. One of the most
important hallmarks of aging is increased genomic instability. However, there
remains much ambiguity as to the cause. I am studying the replicative life span
(RLS) of the genetically tractable model organism Saccharomyces cerevisiae, or
budding yeast using the innovative “mother enrichment program” as the method
to isolate unparalleled numbers of aged yeast cells to investigate the molecular
changes associated with aging. My goal is to determine the possible causes of
loss of genomic integrity during replicative aging in budding yeast to gain
potential insight into this vastly complex process.
In my work presented here, I uncovered a global loss of cohesion in
mitotically aged yeast cells and this most likely serves as the cause of increased
rDNA instability and/or ERC accumulation as observed during aging. These
events, in turn, influence the global genomic integrity in replicatively aged cells.
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Furthermore, I discovered a profound defect in double strand break (DSB) repair
with aging due to limiting levels of key components of the homologous
recombination machinery. This DSB repair defect in old cells limited the
replicative lifespan, because restoration of DSB repair by overexpressing key HR
proteins ameliorated age-associated changes, to extend lifespan. We propose
that the limiting levels of repair factors and cohesin proteins impair the ability of
the aged cells to counteract the increased burden of genomic damage
accumulation coupled with chromosomal rearrangements and potentially
chromosome loss, eventually to cross a threshold of genomic damage that is
sensed by the cell to cause cessation of cell division marking the end of the
replicative lifespan.
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CHAPTER 1: INTRODUCTION

1

Some parts of this chapter are based upon our published review: Pal, S., and
Tyler, J.K. (2016). “Epigenetics and aging”. Science Advances 2, e1600584.
Copyright permission is not required as the copyright policy for this article
published in the journal of Science Advances states that “This is an open-access
article distributed under the terms of the Creative Commons AttributionNonCommercial license, which permits use, distribution, and reproduction in any
medium, so long as the resultant use is not for commercial advantage and
provided the original work is properly cited.”

1.1. General overview of the aging process
In general, propagation of any given organism primarily depends on either
forever maintaining its cellular homeostasis or effectively renewing the population
with healthy young individuals. Nature primarily selected for the latter option
throughout evolution and potentially selected against any organism living forever.
Aging is a complex multi-factorial biological process that is an inevitable outcome
of life and is universally shared by all organisms. Generally, organismal health is
directly proportional to the overall fitness of its organs, tissues, cells and finally
biological macromolecules. It is characterized by a progressive decline of
molecular, cellular, physiological and organismal function in a time-dependent
manner. As an organism ages, its ability to retain normal cellular functions starts
to decline, and susceptibility to diseases and other environmental stresses rises
strikingly. How this functional decline initiates during organismal aging remains
elusive till now. Understanding the molecular details of organismal aging thus
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Figure 1

Figure 1. Decline of cellular functions and accumulation of cellular damage
with aging. A simplified model illustrates that maintenance of proper cellular
homeostasis in young cells is imperative to maintain proper health. However,
with aging functional deteriorations of different cellular functions together with
increased accumulation of cellular damage leads to altered cellular homeostasis
resulting in increased susceptibility to different age-associated conditions,
including cancer, metabolic disorders, cardiovascular diseases and
neurodegenerative disorders.
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holds significant importance for human health because aging serves as the
greatest risk factor for development of many diseases including cancer,
metabolic disorders such as diabetes, cardiovascular disorders,
neurodegenerative diseases and many others (Fig. 1) (1-8). Although the causes
of aging are poorly understood, there are continued efforts to delineate longevity
pathways conserved among all eukaryotes effectively linking physiology with
signal transduction and genetic regulations to mediate extension of health and
lifespan.

1.2. Hallmarks of aging
Over the past years, great strides have been made by numerous groups in
the aging research field that efficiently categorized the cellular and molecular
hallmarks of aging (9). These nine hallmarks are generally considered to be the
pillars greatly contributing to and determining the aging process (Fig. 2). In order
to be considered as a hallmark of aging, these candidates needed to be fulfilling
the following criteria: that this event happens during normal aging, experimentally
worsening this event would accelerate the natural aging process and
experimental improvement of this event delays onset of aging to extend natural
lifespan (9). Although some of these hallmarks are specific for metazoans, the
majority of them are conserved in all eukaryotic organisms from yeast to humans,
including epigenetic alterations and genomic instability (Fig. 3), which will be
further elaborated here.
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Figure 2_v4
Integrative
hallmarks

Primary
hallmarks

Antagonistic
hallmarks

Figure 2. Hallmarks of aging. Schematic representation of nine known
hallmarks of aging in multicellular eukaryotes, while some of them are conserved
across species to unicellular eukaryotes also. The nine hallmarks are further
grouped into three categories of primary, antagonistic and integrative hallmarks
of aging. Epigenetic alterations and genomic instability are conserved aging
hallmarks in multiple organisms and here are categorized as primary hallmarks of
aging, i.e. those that serve as the drivers of aging. (Adapted from: Lopez-Otin,
C., M. A. Blasco, L. Partridge, M. Serrano, and G. Kroemer. 2013. The hallmarks
of aging. Cell 153: 1194-1217. The figure is used with permission from Elsevier
under the license number 4091620498639)

5

Figure 3

Figure 3. Epigenetic alterations and genomic instability during aging. While
in young individuals cells maintain uniformity in their epigenetic information and
also a stable genome, during aging exposures to different exogenous and
endogenous factors result in abnormal chromatin states coupled with increased
genomic instability. (Adapted from: Pal, S., and J. K. Tyler. 2016. Epigenetics
and aging. Science advances 2: e1600584)
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1.2.1. Epigenetic changes during aging
Among these hallmarks, epigenetic alterations represent one crucial
mechanism behind the deteriorated cellular functions observed during aging and
in age-related disorders. By definition, epigenetics represents the reversible
heritable mechanisms that occur without any alteration of the underlying DNA
sequence. Although the chromosomes in our genome carry the genetic
information, the epigenome is responsible for the functional use and stability of
that valuable information. In other words, it connects the genotype with the
phenotype (10-13). These epigenetic changes can either be spontaneous or
driven by external or internal influences. Epigenetics potentially serves as the
missing link to explain why the pattern of aging is different between two
genetically identical individuals, such as identical twins or in the animal kingdom
between animals with identical genetic make-up, such as queen bees and worker
bees (2, 14, 15). Though longevity studies in the human population have shown
that genetic factors could explain a fraction (20-30%) of the differences observed
in the lifespans of monozygotic twins, the majority of the remainder of variation is
thought to have arisen through epigenetic drift during their lifetime (11, 12, 14,
16, 17). Similarly, different environmental stimuli including diet cause differential
alterations of stored epigenetic information to create a striking contrast in
physical appearance, reproductive behavior, and lifespan in queen and worker
honeybees, despite their identical DNA content (18). The resulting variability in
the pattern of epigenetic information within individual cells in the population
during aging, in turn, leads to transcriptional drift and genomic instability. Being
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established by enzymes, epigenetic information is reversible. As such,
epigenetics holds great prospects for targeting by therapeutic interventions,
which may potentially lead the way to the development of novel therapeutic
approaches to delay aging and age-related diseases.
There are different types of epigenetic information encoded within our
epigenome, including but not limited to the presence or absence of histones on
any particular DNA sequence, DNA methylation, chromatin remodeling, posttranslational modifications of the histone proteins, structural and functional
variants of histones, and transcription of non-coding RNAs (ncRNAs) (2, 4, 12).
These different types of epigenetic information together comprise our epigenome
and are important determining factors behind the function and fate of all cells and
tissues, in uni- and multi-cellular organisms. Invariably, each of these different
types of epigenetic information is functionally significant for the process of aging.
Growing evidence in recent years also clearly implicates chromatin structure,
which carries much of the epigenetic information, as a major player during the
aging process. The basic unit of chromatin structure is the nucleosome, which
consists of 147 bp of DNA wrapped around a histone octamer that comprises two
copies of each core histone protein, H2A, H2B, H3 and H4 (19, 20). The addition
of linker histones, such as histone H1, and other non-histone proteins, such as
heterochromatin protein 1 (HP1), facilitate the formation of higher-order
repressive chromatin structures, such as heterochromatin (21). The packaging of
the genomic DNA into the highly organized chromatin structure regulates all
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genomic processes in the nucleus including DNA replication, transcription,
recombination and DNA repair, by controlling access to the DNA (4).
Studies in humans and the powerful models of aging are revealing that,
similar to all other biological structures inside the cells, the epigenome suffers
from a progressive loss in its configuration during aging. This results in a
profound change in the chromosomal architecture, genomic integrity and gene
expression patterns (2, 12). Where examined, these effects are mostly
conserved all the way from single-celled organisms such as budding yeast to
complex multicellular eukaryotes. These conserved mechanisms help us gain a
clearer picture of the aging process.

The heterochromatin loss model of aging
One of the earlier proposed models of aging was “the heterochromatin
loss model of aging” (22, 23). This model suggests that the loss of
heterochromatin that accompanies aging leads to changes in global nuclear
architecture and expression of genes residing in those regions, directly or
indirectly causing aging and cellular senescence. As with any other model of
aging, the heterochromatin loss model is supported by experimental data, but
there are also confounding observations. Loss of transcriptional silencing, due to
decay of the heterochromatin, occurs during aging in all eukaryotes examined
from yeast to humans (22-26), and there is evidence that accelerating or
reversing this process can either shorten or lengthen lifespan, respectively (Fig.
2). Gene silencing requires the absence of histone acetylation within
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heterochromatin regions. Accordingly, treatment with histone deacetylase
(HDAC) inhibitors or deletion of genes encoding HDACs, such as yeast SIR2 or
its sirtuin counterparts in metazoan species, shortens lifespan while chemical
activation or overexpression of SIR2 / sirtuins extends lifespan (27, 28). Yeast
Sir2 was first recognized as an H4 K16Ac deacetylase, while mammalian SIRT1
is an H3 K9Ac / H4 K16Ac deacetylase (27). However, it is now appreciated that
sirtuins do not just deacetylate histones, but also many other transcriptional
regulators and indeed their roles in aging extend far beyond heterochromatin,
including genome maintenance (29). It has been observed previously in budding
yeast that redistribution of Sir proteins from the silent mating type loci to sites of
increased genomic instability during aging causes loss of silencing from
heterochromatic mating type loci to cause sterility and to promote aging (30).
Similarly, the mammalian homolog of Sir2, SIRT1, has been shown to repress
repetitive elements and other regions across the mouse genome. However, in
response to DNA damage, SIRT1 is redistributed from these loci to DNA breaks,
resulting in alterations in gene expression that is comparable to those in the
aging mice brain (29). Therefore, repression of heterochromatic repeat elements
seems to be evolutionarily conserved and extremely critical in lifespan
maintenance (29, 31). Another example where it is clear that loss of
heterochromatin promotes aging is at the rDNA locus, where loss of silencing of
the rDNA promotes genomic instability and aging in budding yeast (32, 33).
Further evidence supporting the heterochromatin loss theory comes from the
analysis of chromatin structures from Hutchinson-Gilford Progeria Syndrome
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(HGPS) patients and most recently from a Werner syndrome stem cell model of
premature aging (12, 34-37). These disorders exemplify how the deregulation of
heterochromatin, illustrated by global loss of heterochromatin marks (discussed
more below) and altered heterochromatin structure, accelerates aging. Although
some of the defects observed in premature aging patients have also been
observed in aged individuals (35), it is still debatable whether the findings are
equally applicable to physiological aging.

Global histone protein reduction during aging
Recently, the aging research field has experienced a leap from the earlier
paradigm of the heterochromatin loss model. Not only is the heterochromatin
reorganized during aging, but in addition, a global loss of core histone proteins
from the genome during aging has been observed in multiple scenarios, and this
has been shown to be a cause of aging in yeast. In budding yeast, replicative
aging is accompanied by loss of approximately half of the core histone proteins
(38, 39). The extensive nucleosome loss from the entire yeast genome during
replicative aging results in globally increased transcription in aged cells (40).
These global changes in transcription and chromatin structure were only
detectable due to the development of novel normalization approaches for
genomic datasets (41). Notably, during yeast replicative aging, not only
transcriptionally silent regions showed dramatic de-repression, but all genomic
regions showed transcriptional up-regulation, presumably due to increased
access of the transcription machinery to the DNA sequences (40). The drastic
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decline of the core histone proteins in S. cerevisiae is due to reduced protein
synthesis of the histones (38). Clearly, the fact that the levels of histone
transcripts, like all other transcripts, actually increase during replicative aging in
yeast (38, 39, 42) has no functional consequence because of the reduced
histone protein synthesis in old yeast. Other cells may indeed use transcriptional
regulation to reduce histone levels during aging because quiescent muscle stem
cell aging is accompanied by reduced histone transcript levels (43). Supply of
extra histone H3 and H4 proteins, either from an inducible promoter, by deleting
the genes encoding the Hir repressor of histone gene transcription, or deleting
the gene encoding the protein Tom1 that is involved in degradation of excess
histone proteins, results in lifespan extension of yeast, identifying loss of histone
proteins as a cause of aging (38, 44). The pathway of lifespan extension utilized
by supplying extra histones appears to be independent from the pathway of
calorie restriction (CR) in budding yeast (38), which is a widely-accepted way to
extend lifespan in seemingly all species (45). Interestingly, the lifespan extension
that results from lithium exposure in worms is accompanied by increased histone
gene expression (46), although it is not known if increased histone gene
expression plays a causative role in lifespan extension. The reduction of bulk
core histone protein levels observed during replicative aging is not restricted to
budding yeast, but has also been observed during aging in worms (47), during
replicative aging of human diploid primary fibroblasts (48) and in senescent
human cells (49). It is noteworthy that global histone loss has not yet been
reported in mitotically dividing mammalian tissues in vivo. In human primary
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fibroblasts, the reduced synthesis of new histones during replicative senescence
was a consequence of the shortened telomeres activating the DNA damage
response (48), potentially explaining the mechanism by which telomere
shortening limits the number of cell divisions. As such, loss of core histones may
be a more generalized phenomenon observed with aging in many organisms.
Decreased levels of core histone proteins in aged cells would likely cause
a dramatic effect on the chromatin landscape by providing inappropriate access
to the genetic material. The consequences of having limiting amounts of histone
proteins on DNA during age progression has been elaborately examined in a
recent global analysis of chromatin from aged cells in budding yeast in
comparison to the young rejuvenated population (40). Most of the nucleosomal
positions are maintained in aged cells, while nucleosome occupancy is reduced
to half the normal proportion, and nucleosome locations on particular DNA
sequences become less stringent, or fuzzier. Additionally, moderate overexpression of histone proteins H3/H4 partially reversed the transcriptional defects
observed during aging. It will be intriguing to investigate in the future whether the
longevity effect conferred by supplying extra histones is equally pertinent in
multicellular organisms.

1.2.2. Genomic instability during aging
Genomic instability represents another major hallmark that has long been
implicated as a major causal factor for aging (9, 50). It refers to alterations in the
genome under physiological conditions in response to endogenous or exogenous
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stresses. The stability and integrity of the genome are under continuous
challenge from these endogenous or exogenous threats. Lesions in the genome
can arise either as chemical damage to the DNA, mutations of actual base pairs
or epimutations of DNA that refers to heritable changes in DNA modifications
affecting gene expression without changing the actual sequence of DNA (9, 50).
The resulting effects of these genomic lesions accumulated in DNA are in
general highly diverse and include point mutations, deletions/insertions,
inversions, transpositions, translocations, chromosomal gains/losses, telomere
shortening etc. While the ability to endure a certain level of changes in the
genomic content of any species is important for its evolvability, too much change
also drives a species towards its extinction. Therefore, very complex yet refined
systems of genome maintenance exist to guard the genome, which is the primary
template for structural and functional information in any organism (50, 51).
Although distinct from the nuclear DNA, changes in mitochondrial DNA and
nuclear architecture can give rise to genomic instability (9). The focus of this
study will be geared towards the genetic instability of nuclear DNA during aging.
As mentioned earlier, the eukaryotic genome is packaged into chromatin
structures. Therefore, a more relaxed chromatin structure observed during aging,
due to heterochromatin loss or histone loss, is predictive of not only
transcriptional deregulation but also genome instability. Indeed, the reduced
nucleosome occupancy in old yeast led to increased genomic perturbations,
including higher levels of DNA breaks, damage foci formation, inter- and intrachromosomal translocations, insertion of mitochondrial DNA into the nuclear
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genome and high levels of retrotransposition (40). Noteworthy, partial overexpression of histone proteins H3 and H4 partially reversed the transcriptional
defects observed during aging and reduced retrotransposition, indicating that the
increased retrotransposition in old yeast was a consequence of histone loss
during aging (40). Increased levels of DNA breaks or unrepaired DNA damage,
as illustrated by formation of γ-H2AX foci (a hallmark of DNA damage) have been
observed in cells from multiple species including aged mice, senescent human
cells and cells derived from patients with premature aging disorders (52-55). In
addition, other forms of DNA damage including copy number variations and
chromosomal aneuploidy have also been shown to be associated with increased
age (56, 57). This evidence suggest that DNA damage may be a driving force
behind organismal aging, although the full extent of the role of DNA damage
during age progression still needs to be explored.
One form of genomic instability observed during aging that results from
heterochromatin decay is increased mobility of endogenous genetic elements,
called retrotransposable elements. Retrotransposable elements have been
implicated in the aging process by several lines of evidence across organisms
including budding yeast, flies, worms, mice and even during cellular senescence
in adult human stem cells (40, 58-63). Retrotransposable elements are tightly
silenced by heterochromatin in young cells/organisms. However, the loss of
heterochromatin with aging leads to increased expression of otherwise silent
retrotransposons, essentially causing transposition of these elements, because
the transcripts are reverse transcribed to make a genomic cDNA copy that gets
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integrated elsewhere into the genome. The end result is increased mobility of
retrotransposable elements within genomes, resulting in disruption of cellular
homeostasis during aging (64). Proof that the loss of chromatin-mediated
silencing of retrotransposable elements during the course of aging directly leads
to their increased transposition during aging came from the ability to repress Ty
transcription and retrotransposition in old yeast by overexpressing histones (40).
Lifespan-extending interventions, such as calorie restriction, have also been
shown to counteract the increased expression of retrotransposons in aged mice
(63).
As mentioned previously, sirtuins play important roles not only in
deacetylating histones but also in their roles in genome maintenance (29). In
addition to redistribution of Sir proteins from the silent mating type loci to sites of
increased genomic instability during aging to cause loss of silencing from mating
type loci and to promote aging in budding yeast (30), in mice SIRT1 has also
been shown to repress repetitive elements and other regions across the genome.
In response to DNA damage, SIRT1 is redistributed from these loci to DNA
breaks, resulting in alterations in gene expression comparable to those in the
aging mice brain (29). Another example where it is clear that loss of
heterochromatin promotes aging is at the rDNA locus, where loss of silencing of
the rDNA promotes genomic instability and aging in budding yeast (32, 33). The
most recent evidence for sirtuin proteins acting in genome maintenance come
from studies focusing on SIRT6. While the lifespan of transgenic male mice overexpressing Sirt6 is significantly longer than WT mice (65), SIRT6 deficient mice
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are smaller in size, have acute early-aging degenerative phenotypes and early
death (66). In the absence of SIRT6, increased genomic abnormalities and
increased sensitivity to DNA damaging agents were observed, implying roles of
SIRT6 in genome maintenance (66). Another study of SIRT6 in mouse cells
showed that it has ADP-ribosylase activity and SIRT6-mediated mono ADPribosylation of KAP1 promotes its interaction with HP1 and the packaging of L1
LINE elements into repressive heterochromatin (67). During aging, SIRT6 is
sequestered away from the L1 elements, presumably to DNA breaks elsewhere
in the genome, resulting in activation of the retrotransposons (67). Recently, it
has also been shown that SIRT6 is responsible for rescuing the declining
efficiency of homologous recombination in vitro during senescence of human
fibroblasts (68). All these evidence further emphasize the critical roles of sirtuin
proteins in genome maintenance, and lifespan extension (29, 31).
It is a long-standing belief that accumulation of DNA mutations over a
period of time impacts organismal aging, as mutation accumulation happens as a
function of age in different organisms such as flies or mice, and in some cases
also correlates with lifespan (69, 70). However, a recent study indicated that
accumulation of somatic DNA mutations at least in budding yeast does not have
a causal role in aging (71). Therefore, it is yet to be conclusively determined if the
persistent DNA damage observed in aging cells is the result of increased
susceptibility of the accessible genome to accumulate DNA damage with time or
the inability of aged cells to efficiently repair the damage or a combination of
both. It has been hypothesized for a long time that a declining DNA repair
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response is a possible contributing factor for the increased DNA damage
observed during aging, thus contributing to the aging process itself (51, 72).
Notably, another recent analysis of the DNA repair transcriptome of liver in
species with significant lifespan differences revealed that the longer-lived species
express certain DNA repair genes at higher levels compared to species with
shorter lifespan, suggesting a superior genome maintenance mechanism in the
longer-lived species, which could potentially be responsible for their longer
lifespan (73).
Importantly, cancer is considered a disease of aging as cancer
development exponentially increases in the aging human population, but the
mechanism by which aging predisposes cells to cancer initiation still remains
elusive (74, 75). Aging and cancer, in the majority of instances, share common
etiologies (76). The increased genomic instability that is a prominent hallmark for
aging also serves as one of the primary hallmarks of cancer (9, 77). Thus,
understanding the events associated with an increase in genomic instability
during aging will also enhance our knowledge about carcinogenesis, and
therefore help in the accurate prediction, effective treatment, and prevention of
cancer.
Noteworthy, the processes described in this section are unlikely to
function independently from each other, and one event may lead to another
during the aging process. For example, heterochromatin decay and histone loss
may lead to increased genomic instability and changes in gene expression. In
consideration of the increase in genome instability during aging, strong lines of
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evidence are there to demonstrate genomic alterations in aging cells but how it is
causally related to aging needs further exploration. We are currently limited in our
knowledge of the sequence of the causal events during aging in healthy
individuals. Given the complexity of the genome maintenance mechanisms in
eukaryotic cells and the redundant roles played by different factors, it is difficult to
model physiological aging in any given model organisms. Attempts should be
made in the near future to define the cascade of events during age progression
to attain a comprehensive view of the aging process.

1.3. Human aging disorders and genomic instability
The importance of genome maintenance mechanisms on the aging
process is further exemplified by different premature aging disorders, the majority
of which result from defects in genes important for DNA repair pathways (78, 79).
Hutchinson-Gilford Progeria Syndrome (HGPS), Werner syndrome (WS),
Cockayne syndrome (CS) and trichothiodystrophy (TTD) are rare human genetic
disorders characterized by premature aging phenotypes with a shortened
lifespan (79). This group of diseases resembles physiological aging to a certain
extent, serving as excellent models to gain insight into the biology of aging in
humans (80, 81). These diseases are either due to mutations in genes involved
in the DNA repair pathways or the A-type lamin, leading to defective DNA
damage response and/or disorganized chromatin structures (78, 79, 82). The
causative mutations behind these progeria syndromes indicate that genomic
instability and chromatin deterioration are causes of human aging. Furthermore,
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the knowledge we gain from understanding the molecular pathology of these
human premature aging diseases provides us with useful information to
understand the complex aging process. Individuals with progeric syndromes do
not always recapitulate all aging phenotypes, as they usually show segmental
progeria affecting multiple tissues (79). Furthermore, the accelerated aging
phenotypes observed in these disorders may not be solely due to the
chromatin/repair defects, but a considerable contribution of ineffective genome
maintenance to these disease etiologies has to be acknowledged. By
recapitulating some molecular and cellular changes characteristic of the natural
aging process, these models provide us with a unique opportunity to understand
the aging process in a human model (80, 81).

1.4. Use of model organisms for aging studies
Use of model organisms in studying aging is invaluable for laying the
groundwork in this field of study. Much of our knowledge of aging today comes
from the studies in different model organisms (83, 84). Studies on the aging of
mammals are rather limited by the long lifespan of the commonly used model
organisms. Both non-vertebrate and invertebrate organisms, with their shorter
lifespan and ease of genetic and environmental manipulations, are popular
among researchers in the aging field as experimental models for aging studies.
Among them, budding yeast or Saccharomyces cerevisiae is a highly informative
organismal model for aging studies with its genetic tools, short lifespan and fully
sequenced genome (85, 86). It is also possible to investigate mitotic and post-
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mitotic aging in this model organism. Though unicellular, budding yeast has been
an excellent model to identify and characterize conserved basic biological
processes, including aging (5, 6). It has been extensively used for identifying
genes and interventions responsible for lifespan extension, to gain insights
relevant to the aging processes of all eukaryotic organisms. In parallel, over the
years studies in invertebrate organisms such as Drosophila melanogaster (flies)
and Caenorhabditis elegans (worms) and in certain vertebrate models such as
mice, zebrafish, naked mole rats and most recently African turquoise killifish
have also provided invaluable information to help us understand the complexity
of the process of aging and the effect of overlapping pathways influencing
longevity (5, 8, 84). Both flies and worms have a relatively short lifespan and are
extensively used to characterize the involvement of different genetic pathways in
longevity, but both of these model organisms primarily focus on post-mitotic
aging (5). African killifish rather recently provided the aging field with a short-lived
vertebrate model that recapitulates age-associated human pathologies, but this
model system is the newest in the field and yet to be developed fully (84). On the
other hand, mice and zebrafish represent well-established vertebrate models of
aging those are evolutionarily closer to humans. In particular, the available
resources and different models of aging including premature aging and long-lived
aging mice were instrumental in our current understanding of this complex
process (5). However, the relatively longer lifespans of mice and zebrafish
models (3-4 years and 5 years, respectively) make the experimental aging
studies in these models more complicated (5, 84). In addition to these model
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organisms, accelerated aging disorders in humans or progeria syndromes also
provide some insightful details of the aging process (5, 6). Having taken all these
variable factors into consideration, we utilized Saccharomyces cerevisiae or the
budding yeast as our experimental model in our study. In this unicellular model
organism, we can distinguish and characterize mitotic aging (Replicative aging)
from post-mitotic aging (Chronological aging) very easily. In this study, our entire
focus will be on the replicative aging or mitotic aging in budding yeast. Since the
replicative age curve of budding yeast follows the same shape as the lifespan
distribution in multicellular eukaryotes and the majority of the cellular processes
are conserved among all eukaryotes, the knowledge I gain from my studies in
budding yeast has the potential to be directly relevant to understanding the aging
of multicellular eukaryotes, including humans.

1.4.1. Chronological aging in budding yeast
Chronological lifespan (CLS) is the aspect of longevity in budding yeast
that measures the amount of time a cell is viable in a quiescent or non-dividing
state (87, 88). It is a model of aging for non-dividing cells in multicellular
eukaryotes. During CLS, following the initial growth phase, the cells are normally
maintained in a postdiauxic phase that is a high metabolism phase, followed by a
low metabolism stationary phase until death (88). Experimentally, CLS is
commonly achieved by initially growing the yeast cell population in rich medium
until it reaches a saturation level and then maintaining the cells in the same
media without further replenishing any components. In the rich medium, yeast
cells grow very rapidly, but then they go through first the diauxic shift and stop
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growing. Then there is another switch from the fermentative stage to respiratory
metabolism, following which the cells resume growth at a very slow rate, followed
by cell cycle arrest and entry into the low metabolism stationary phase (88).
While many different pathways have been implicated so far in regulation of
chronological lifespan in yeast, a consensus mechanism for its regulation is yet
to be developed, but nutrient sensing pathways, mitochondrial respiratory
capacity and oxidative stress responses seem to play vital roles in regulating
CLS (87).
1.4.2. Replicative aging in budding yeast
The second aspect of longevity that is extensively studied in budding
yeast is Replicative lifespan (RLS), which is the measurement of the reproductive
potential of a yeast mother cell achieved by measuring the number of times a
mother cell produces a daughter cell before entering senescence. This is a
model of aging for mitotically dividing cells in multicellular eukaryotes (Fig. 4) (87,
89-91). Budding yeast divides a finite number of times, and in general, the
median lifespan for a yeast mother cell is around 25 generations (89). RLS
assays utilize the asymmetric division of budding yeast and the size difference
between the mother and daughter cells to its advantage. This means after each
cell division the daughter cell produced is rejuvenated, i.e. its age clock is set
back to zero, and the aging factors are asymmetrically segregated to the mother
cell. Conceptually the assay is simple and relies on the fact that when a mother
cell produces a daughter cell by budding, the size of the daughter cell is smaller
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Figure 4. Replicative aging model in budding yeast. Replicative aging of
budding yeast as the model of mitotic aging of dividing cells in multicellular
eukaryotes. It represents the reproductive potential of an individual yeast mother
cell, measuring the number of times a mother cell divides before entering
senescence. M indicates mother cell, while D indicates daughters.
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and distinguishable from the mother cell. Towards the end of its life cycle, the
mother cell increases in its size (89, 92-94) and develop a loose and wrinkled
appearance (89, 95, 96), and starts to produce daughter cells that are larger in
size, with apparent breakdown in the asymmetric division (94). With age, old
mother cells also start to produce daughters with heterogenous morphologies
that include both spherical and ellipsoidal shapes (92).
Budding of the daughter cell from the mother cell leaves behind a new bud
scar, which is mainly composed of chitin, on the surface of the mother cell (97).
Replicative age of a mother cell can be determined via staining of the yeast cell
wall by calcofluor and counting the number of bud scars on the mother cell
surface that represents how many daughter cells the mother cell has produced.
However, the more precise method of measuring replicative lifespan, namely
micromanipulation, involves manual separation of daughter cells from a mother
cell using a standard tetrad dissection microscope (87). Although enabling
accurate determination of the RLS, the process is labor-intensive as well as low
throughput. More recently, high-throughput methods have been developed to
study budding yeast during the RLS using microfluidic systems coupled with
high-resolution microscopy at the single cell level (92, 98), that can efficiently
measure cell morphology and other aging-associated characteristics. Attempts to
isolate old mother cells for molecular analyses previously have used either the
elutriation method (42) or affinity purification of mother cells following cell wall
labeling with biotin (24, 99). However, isolation of a large amount of old mother
cells is difficult because the daughter cells quickly outpopulate the old cells. The
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end result is that these methods are only able to isolate aged cells that have
undergone less than 15 divisions. Recently, the development of another powerful
genetic system called “mother enrichment program (MEP)” improved the ability to
obtain a larger amount of older aged mother cells (100).

The “Mother Enrichment Program (MEP)”
The more recently developed genetic method of isolating old mother cells,
called mother enrichment program (MEP), utilizes an inducible selection against
daughter yeast cells coupled with a biotin purification system of the mothers
(100). Selection against daughter cells is achieved by disruption of two essential
genes, CDC20 and UBC9, only in daughter cells using Cre-lox recombination.
The expression of Cre is regulated by the transcription factor Ace2, which is
specifically expressed in daughter cells owing to the asymmetric division of
budding yeast. Cre activity is also inducible in nature as it is a fusion protein
between Cre and estradiol-binding domain of the estrogen receptor (CreEBD78). Induction of Cre activity is achieved by the addition of estradiol which
mediates translocation of the fusion protein Cre-EBD78 to the nucleus, where
Cre functions to disrupt the two essential genes (CDC20, UBC9) via its
recombinase activity, resulting in permanent mitotic arrest of daughter cells
selectively (Fig. 5) (100). For the purification step, a biotin pulse is used to label
the initial mother cell population so that the mother cell wall is coated with biotin.
This biotin labeling is only restricted to the cell surface of mothers as the cell wall
synthesis in budding yeast is generated de novo (24), meaning that the biotin is
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Figure 5. Model of the “mother enrichment program (MEP)”. Illustration of
the genetic system called the MEP, to selectively induce mitotic arrest of
daughter cells via estradiol induced Cre-loxP mediated deletion of two essential
genes, and to allow yeast mother cells to continue replicating and age. This
genetic method coupled with a biochemical purification approach provides a
powerful system to isolate replicatively aged mother cells. (Adapted from:
Lindstrom, D. L., and D. E. Gottschling. 2009. The mother enrichment program: a
genetic system for facile replicative life span analysis in Saccharomyces
cerevisiae. Genetics 183: 413-422, 411SI-413SI)
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non-transferrable to newborn daughter cells. After aging the cells in liquid culture
in the presence of estradiol to ensure the mitotic arrest of daughter cells, it is
possible to magnetically sort the starting population of biotin-labeled old mother
cells utilizing the high-affinity interaction of biotin and streptavidin (100).
Throughout my studies presented here, I extensively utilized this highly efficient
genetic system to isolate sufficient numbers of aged mother cells at a much older
age than previously possible to analyze the events determining yeast replicative
lifespan as a model for aging of mitotically dividing cells of multicellular
eukaryotes. These analyses enabled me to gain potential insight into the natural
aging processes and to broaden our overall knowledge in the aging research.

1.5. Structure of the yeast rDNA locus and connection with aging
1.5.1. Structure of yeast rDNA
The ribosomal RNA gene cluster, also known as the rDNA locus is a
unique locus in the eukaryotic genome. It has a large number of tandemly
repeated sequences, comprising both genes and intergenic regions with noncoding elements (Fig. 6). In budding yeast, the rDNA locus resides within the
nucleolus in a single cluster on chromosome XII and contains approximately 150
tandemly repeated copies in the haploid genome. The rDNA locus occupies
approximately 60% of the chromosome and almost 10% of the budding yeast
genome. The rDNA cluster is critical as it produces the structural RNA
components of ribosomes, serving a crucial housekeeping function in the cell
(33, 101, 102). The rRNA genes are the most abundant genes and are highly
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Figure 6. Structure of the yeast rDNA locus. The budding yeast rDNA locus is
a part of chromosome XII right arm, comprising of ~150 tandem repeating arrays.
Each repeat (~9.2 Kb) contains 35S rDNA and 5S rDNA genes, and intergenic
spacer regions NTS1 and NTS2. The NTS1 region contains a bidirectional
promoter E-pro, which is normally silenced via recruitment of Sir2, and contains a
replication fork barrier (RFB) site, which is bound by Fob1. The NTS2 region
contains a replication origin (ARS) and a cohesin associating region (CAR).
(Adapted from: Ganley, A. R., and T. Kobayashi. 2014. Ribosomal DNA and
cellular senescence: new evidence supporting the connection between rDNA and
aging. FEMS yeast research 14: 49-59.)
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conserved across species (33). In budding yeast, rRNAs (26S, 18S, and 5.8S)
are transcribed from 35S rDNA repeats by RNA polymerase I and then mature
into three individual rRNAs via splicing. 5S rRNAs are independently transcribed
from 5S rDNA repeats located in between two 35S repeats (Fig. 6). All these
rRNAs together form the ribosome structure along with ribosomal proteins (102).
Repetitive in nature and actively transcribing, the rDNA is one of the most fragile
sites in the genome and highly recombinogenic resulting in frequent fluctuations
in rDNA copy numbers (103). Though earlier studies primarily emphasized its
roles in ribosome biogenesis, later evidence underscores its extra-coding
functions including crucial roles in determining lifespan (33, 102).
An individual rDNA repeat is approximately 9.2 Kb in size, consisting of
two rRNA genes (35S rRNA and 5S rRNA) and two non-transcribing spacer
regions (NTS1 and NTS2). The NTS2 region contains a replication origin (ARS)
and cohesin associating region (CAR). The NTS1 region contains a replication
fork barrier (RFB) site, which is responsible for inhibiting rightward movement of
the replication fork, through the action of a specific protein, Fob1. The RFB
prevents the replication fork from colliding with RNA polymerase I, and results in
a DNA double-strand break during replication that can be used to maintain the
proper number of rDNA repeats via sister chromatid recombination. The NTS1
region further contains a bidirectional promoter, E-pro, which is normally silenced
via recruitment of a silencing complex that includes Sir2 (Fig. 6). The rDNA
cluster is unique in this way that it contains all these diverse genomic elements
(33, 101-103).
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1.5.2. The ERC (extrachromosomal rDNA circle) theory of aging
The rDNA locus has long been implicated in genome maintenance, having
critical effects on lifespan in yeast and Drosophila (25, 33, 102, 104). The rDNA
is located within the nucleolus of the cell and aging yeast cells typically display
the phenotype of nucleolar enlargement and fragmentation, which serves as an
indicator of rDNA changes with aging (105, 106). An initial aging theory was
proposed that emphasized the roles of extrachromosomal rDNA circles (ERCs)
as causative agents for yeast aging (32). According to this theory, ERCs are
excised from the rDNA locus mostly due to unequal sister chromatid
recombination between the rDNA repeats. When excised, they form circular
loops with the ability to replicate because of the presence of autonomous
replicating sequence (ARS) elements in them. These ERCs are asymmetrically
segregated to yeast mother cells, causing aging mother cells to accumulate
ERCs exponentially (32, 107). This inherent instability of the rDNA locus because
of its RFB and its tandem repeats, together with the asymmetric segregation of
ERCs serving as aging factors in the yeast mother cells may provide an
explanation for why there is an enlarged and fragmented nucleolus during aging.
Although it is unknown exactly how ERCs form during aging or how ERCs cause
aging, it has been proposed that exponential accumulation of ERCs in aged
yeast mother cells may possibly titrate away factors important to maintain diverse
nuclear functions including replication, transcription or genome maintenance
(32). Validation of this model of aging comes from lifespan analysis of certain
mutants, such as sir2 and fob1 mutants, where increased accumulation of ERCs
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lead to shortening of lifespan (in the sir2 mutant) and decreased accumulation of
ERCs lead to lifespan extension (in the fob1 mutant) (108-110).

1.5.3. rDNA theory of aging
While ERC accumulation had been proposed earlier as a cause of aging
in yeast (32), in several other instances it has been observed that there is an
inverse correlation between accumulation of ERC levels with lifespan and
lifespan cannot always be explained by the ERC theory of aging (104, 111, 112).
Thus, later studies suggested ERCs were merely a byproduct of rDNA instability
and that the rDNA instability itself was the regulator of aging (102, 104, 109,
112). Notably, the rDNA locus is one of the most unstable regions in the budding
yeast genome (112). In the rDNA theory of aging, instead of the accumulation of
ERCs, rDNA instability itself has been proposed to be the major driving force
behind yeast aging (112). At the molecular level, transcription from the intergenic
regions of the rDNA locus that occurs in sir2 mutants has been proposed to
specifically displace cohesin from the rDNA leading to unequal sister chromatid
recombination, rDNA instability and aging (112, 113). The rDNA theory of aging
proposes that being already unstable, the rDNA locus shows more sensitivity to
the age-associated accumulation of DNA damage compared to other parts of the
genome, and that the unstable rDNA locus serves as a DNA damage sensor that
eventually induces senescence in aging cells (112). Evidence supporting this
theory comes from a study partially decoupling ERC levels with rDNA instability
by using strains with different strengths of rDNA replication origins (rARS) (104).
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Here two strains with differing rARS activities, one with increased and the other
with decreased ERC levels, lived shorter than a wild-type (WT) strain, but both
displayed increased rDNA instability in terms of marker loss assays and a less
intact chromosome XII (104). Although several other studies suggested the rDNA
theory of aging would better explain the connection of rDNA to aging than the
ERC theory of aging (112), the causal relationship of this theory has not yet been
tested in the context of physiological aging in budding yeast.

1.6. DNA double-strand break (DSB) repair in yeast and connections with
aging
1.6.1. DNA double-strand break (DSB) repair in yeast
The integrity of the genome is under constant threat due to exposure to
different exogenous and endogenous damaging agents. Exposure to damage
generates a variety of DNA lesions including, but not limited to, DNA singlestrand break (SSB) and DNA double-strand break (DSB) formation. Among all
different DNA lesions, the most deleterious kinds are DSBs because they can
lead to loss of chromosome arms. In order to faithfully maintain chromosomal
integrity, the DSB need to be accurately repaired. Thus, cells possess several
complex and intricate but related signal transduction and repair pathways that
efficiently repair the DNA (114-116). The elaborate system of repairing the DSBs
within the cells is called the DNA damage response that includes sensing the
damage, transducing the signals and efficiently repairing the DNA (115). Along
with the numerous proteins involved in these signal transduction pathways, there
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is involvement of different post-translational modifications as well. The major
pathways to repair DSBs are homologous recombination (HR) and nonhomologous end joining (NHEJ). HR is considered as an error-free repair
pathway while NHEJ is widely regarded as a more error-prone repair pathway
(117-119).
HR is the primary DNA repair pathway utilized by budding yeast in
response to DSBs (117). The crucial step for HR is the invasion of singlestranded DNA (ssDNA) generated following resection into a homologous DNA
duplex (119). In budding yeast, following DSB formation, repair by the HR
pathway involves DNA end processing/resection by Mre11-Rad50-Xrs2, known
as MRX (MRN in mammals) and the Sae2 protein, followed by Replication
Protein A/RPA loading onto ssDNA. The RPA is removed and replaced by the
ssDNA providing a substrate for Rad51 nucleoprotein filament assembly. There
are a few critical mediators, such as Rad52, in budding yeast that promote
Rad51 binding. Rad51 assembly onto the ssDNA, assisted by Rad52 and other
proteins, is needed for strand invasion into the duplex DNA of the sister
chromatid. The 3’ end of the invading strand provides a primer for repair
synthesis while the intact sister chromatid serves as the template. The strand
invasion intermediate (D-loop) can then be resolved in a number of ways, leading
to either crossover (CO) or non-crossover (NCO). But in either scenario, precise
information is copied from the sister chromatid template to drive error-free repair
and to restore the genomic information (Fig. 7) (116, 117, 119, 120).

34

Figure 7

Figure 7. Key steps of homologous recombination (HR) in budding yeast.
Upon induction of a DSB, the Mre11-Rad50-Xrs2 (MRX) complex is recruited to
DSB sites to drive end resection of DSB ends generating single-stranded DNA
(ssDNA). RPA hetero-trimers then bind to the ssDNA ends and is subsequently
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replaced with RAD51 nucleoprotein filament formation. The RAD51/ssDNA
complex invades the complementary sister chromatid strand in search of
homology, and then, DNA synthesis occurs. HR repair is completed following the
resolution of resulting Holliday junction. (Adapted from: Jasin, M., and R.
Rothstein. 2013. Repair of strand breaks by homologous recombination. Cold
Spring Harbor perspectives in biology 5: a012740., and Mehta, A., and J. E.
Haber. 2014. Sources of DNA double-strand breaks and models of
recombinational DNA repair. Cold Spring Harbor perspectives in biology 6:
a016428.)
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1.6.2. Connection of impairment of DNA repair with aging
As mentioned earlier, one important hallmark of aging is increased
genomic instability due to constant insults from numerous DNA damaging
agents, and it has long been implicated as a causal factor behind aging (9, 50).
Of note, premature aging syndromes in humans are often characterized by
defects in genes involved in DSB repair, such as WRN, which is involved in both
HR and NHEJ repair pathways, is mutated in Werner syndrome (121-123).
Maintenance of genomic integrity thus remains a major mechanism to retain
viability and promote longevity (79). Our earlier studies showed that replicative
aging in budding yeast is associated with significant increases in DNA breaks,
DNA amplifications and chromosomal translocations (40). As HR is the major
pathway of DNA repair in budding yeast, defects in the HR pathway could
potentially account for the defective DNA repair that occurs in old yeast cells
leading to these chromosomal rearrangements and more DNA damage. It is
intriguing to observe that DNA lesions accumulate to such a great extent during
aging, given that the DNA repair system is highly proficient in nature and
abundant in cells (50). This observation leads to the prediction that the DNA
repair activity would decline with aging (123, 124). Declining DNA repair
efficiency during aging has so far been reported only in C. elegans at the
organismal level, although the exact mechanism is yet to be characterized (125).
There are additional instances of reduced DSB repair activity in aging rat
neurons and cultured primary human cells (68, 126-128), as well as in peripheral
lymphocytes from aged humans (129-131), indicating the generalized nature of
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an impaired DNA repair system during aging among all eukaryotes. Using the
replicatively aged yeast cells, it is possible to determine whether this decline in
repair efficiency occurs during aging and whether this contributes to genomic
instability and aging.
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CHAPTER 2: MATERIALS AND METHODS
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2.1. Yeast strains
All the yeast strains used in this study are haploid strains and are listed in Table
1. Yeast deletion mutants were made by homologous recombination-mediated
gene replacement, that is the replacement of the open reading frame of a specific
gene with a selection marker gene. Tagging yeast strains with an HA epitope tag
at the C-terminus of a specific gene was achieved by PCR-mediated DNA
fragment integration followed by selection for the appropriate marker. The
pFA6a-3XHA-KANMX6 Longtine vector was used as the PCR template to
generate the DNA fragment for making C-terminal 3XHA tagged strains (132).
Over-expression of a single copy gene was achieved by integrating yeast
integrative vectors with a HIS3 marker containing the specific genes with the
flanking sequence. Standard YEP media and SC media were used to grow yeast
cells. YSI129 and YSI130 strains were kindly gifted to us by T. Kobayashi (133).

Strain

Genotype

Source

ZHY2

MATalpha ade2::hisG his3 leu2 met15Δ::ADE2
trp1Δ63 ura3Δ0:: URA3 hoΔ::SCW11pr-Cre-EBD78NatMX loxP-UBC9-loxP-LEU2 loxP-HPMX
MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0
rad52∆::KANMX
MATalpha ade2::hisG his3 leu2 met15D::ADE2
trp1D63 ura3D0:: URA3 hoD::SCW11pr-CreEBD78-NatMX loxP-UBC9-loxP-LEU2 loxP-HPMX
MCD1-6HA:his5+
MATalpha ade2::hisG his3 leu2 met15D::ADE2
trp1D63 ura3D0:: URA3 hoD::SCW11pr-CreEBD78-NatMX loxP-UBC9-loxP-LEU2 loxP-HPMX
fob1∆::KANMX4
MATa ade2-1 ura3-1 his3-11 trp1-1 leu2-3,112
can1-100 fob1∆::LEU2 his3-11::GFP-LacI-HIS3
RDN1::LacO(50)-ADE2 (110 rDNA copies)

Hu et al,
Genes & Dev,
2014
Giaever et al,
Nature, 2002
This study

rad52Δ
SPY006

SPY021

YSI129
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This study

Ide et al,
Science,
2010

YSI130
SPY056
SPY065
SPY048

SPY054

SPY031

SPY074

SPY025

MATa ade2-1 ura3-1 his3-11 trp1-1 leu2-3,112
can1-100 fob1∆::LEU2 his3-11::GFP-LacI-HIS3
LacO(50)-ADE2:445kb ChXII (110 rDNA copies)
MATa ade2-1 ura3-1 his3-11 trp1-1 leu2-3,112
can1-100 MCD1-6HA:his5+
MATa ade2-1 ura3-1 his3-11 trp1-1 leu2-3,112 Epro∆::GAL1/10-URA3 MCD1-6HA:his5+
MATalpha ade2::hisG his3 leu2 met15D::ADE2
trp1D63 ura3D0:: URA3 hoD::SCW11pr-CreEBD78-NatMX loxP-UBC9-loxP-LEU2 loxP-HPMX
RAD54-3HA::KANMX6
MATalpha ade2::hisG his3 leu2 met15D::ADE2
trp1D63 ura3D0:: URA3 hoD::SCW11pr-CreEBD78-NatMX loxP-UBC9-loxP-LEU2 loxP-HPMX
SAE2-3HA::KANMX6
MATalpha ade2::hisG his3 leu2 met15D::ADE2
trp1D63 ura3D0:: URA3 hoD::SCW11pr-CreEBD78-NatMX loxP-UBC9-loxP-LEU2 loxP-HPMX
RAD51-HIS3
MATalpha ade2::hisG his3 leu2 met15D::ADE2
trp1D63 ura3D0:: URA3 hoD::SCW11pr-CreEBD78-NatMX loxP-UBC9-loxP-LEU2 loxP-HPMX
MRE11-HIS3
MATalpha ade2::HisG his3 leu2 met15∆::ADE2
trp1∆63 ho∆::SCW11pr-CRE-EBD78-NatMX loxPUBC9-loxP-LEU2 loxP-CDC20-Intron-loxP-HPHMX
ade3::GAL HO

Ide et al,
Science,
2010
This study
This study
This study

This study

This study

This study

This study

Table 1: A list of yeast strains used in this study

2.2. Yeast media and plates
YEP (yeast extract peptone) media: To make 1L YEP, 10 g of yeast extract and
20 g of peptone were dissolved in 900 ml distilled water. The yeast media was
sterilized by autoclaving at 120°C for 20-30 min. For YEP, either glucose (20%
w/v stock, sterilized by autoclaving), galactose (20% w/v stock, sterilized by
filtration) or raffinose (20% w/v stock, sterilized by filtration) was added to make
YEPD or YEPR respectively to make a final concentration of 2% of the
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appropriate sugar. To make solid media plates, 1.5% agar A was added to the
liquid media prior to autoclaving.

2.3. Yeast genomic DNA isolation
Yeast genomic DNA was isolated as previously described (134). Cell pellets from
overnight cultures were resuspended in 200 µl genome preparation buffer (2%
Triton X-100, 1% SDS, 100 mM NaCl, 10 mM Tris-HCl pH 8.0), 250 µl glass
beads, and 250 µl phenol:chloroform:isoamyl alcohol (25:24:1) and then vortexed
in the cold room for 5 minutes. The sample was centrifuged for 5 minutes at
maximum speed at room temperature and the top aqueous layer was transferred
to a fresh microfuge tube. 1 mL 100% ethanol was added to the sample and
mixed well before centrifugation for several minutes until a small pellet of DNA
was obtained on the side of the tube. Finally, the pellet was washed twice with
70% ethanol, the excess ethanol was removed, and the pelleted DNA was
resuspended in 200 µl millipore water for further application.

2.4. Yeast transformation
Yeast transformation was performed using the lithium acetate method and singlestranded salmon sperm DNA as the carrier DNA (135). In brief, cultures were
inoculated into 5 ml of YEPD for growing overnight at 300C. The following
morning, overnight cultures were diluted to an optical density (OD600) of 0.3-0.4 in
5 ml fresh YEPD media and allowed to double in density at 300C to reach OD600
of 0.8. Cells were then spun to get a pellet and the pellet was washed in 1X TE /
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1X LiAc (10 mM Tris-HCl pH 8.0, 1 mM EDTA, 100 mM LiAc) and vortexed
vigorously for 30 seconds before finally resuspending in 50 µl of 1X TE / 1X LiAc
solution. In a separat tube, 10 µl of denatured salmon sperm DNA and 3-5 µl of
transforming DNA (either a plasmid or PCR amplified product) were mixed and
then added to the resuspended cell pellet. 300 µl of polyethylene glycol (PEG)
solution (40% PEG, 100 mM LiAc, 10 mM Tris-HCl pH 8.0, 1 mM EDTA) was
then added to the cell suspension followed by addition of 50 µl DMSO. The
resuspension was mixed thoroughly by vortexing followed by incubation at 300C
for 10 min and heat shock at 420C for 20 min. Following the incubations, cells
were spun and washed in YEPD media before resuspending in 100 µl distilled
water and plating in appropriate selection agar media plates to grow yeast
colonies.

2.5. Purification of old cells by the mother enrichment program method
Isolation of aged cells was performed using the “mother enrichment program”
(MEP), as described previously (40, 100). Briefly, 2x107 cells from YEPD (1%
yeast extract, 2% peptone, 2% dextrose) mid-log phase culture were collected
and washed twice in 1X PBS, followed by resuspension in PBS containing 3
mg/ml Ez-link Sulfo-NHS–LC-LC biotin (Thermo-scientific, P121338). Cells were
incubated at room temperature for 30 min and washed twice using YEPD. These
cells were used to seed a culture at a density of 2x 104 biotinylated cells per ml in
YEPD. 17β-Estradiol (Sigma, E8875) was added to a final concentration of 1 µM
to initiate the MEP and cells were cultured at 30°C for 30 hours to obtain cells of
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desired age (confirmed by calcofluor staining). Typically, cultures were 2L in
volume. At the collection time, cells were collected via centrifugation and washed
twice in PBS, resuspended at a density of 5x108 cells/ml in 1 ml of PBS, and
incubated for 30 min at room temperature with 50 µl streptavidin-coated magnetic
beads (Miltenyi Biotec, NC9821945). After streptavidin incubation, cells were
washed in PBS, resuspended in 8 ml of PBS, and loaded onto an LS MACS
column (Miltenyi Biotec, NC9777034) equilibrated with 5 ml of PBS. After gravity
flow-through of unlabeled cells and debris, columns were washed thrice with 8 ml
of PBS. The columns were then removed from the magnetic field and aged cells
were eluted by gravity flow with 8 ml of PBS, and processed accordingly for the
subsequent experimental purpose.

2.6. Purification of old cells by serial biotin purification
Yeast old mother cells were isolated using 2–3 rounds of purification; the initial
population of cells was labeled with 3 mg/ml biotin (Thermo-scientific, P121338)
in 10 ml cultures for 30 minutes, then the cells were washed with 1X PBS, 3
times to remove the biotin, cultured overnight, followed by affinity purification
using 50 µl streptavidin-coated magnetic beads (Miltenyi Biotec, NC9821945) in
LS MACS column (Miltenyi Biotec, NC9777034) in the cold room following
published method (136). Mean ages of isolated cells were estimated by counting
Calcofluor-stained bud scars. Briefly, cells were grown in YEPD media to
OD600 of 0.7. Then the cells were spun, washed twice with in 1X PBS, and
resuspended in cold 1X PBS. 3 mg/ml Ez-link Sulfo-NHS–LC-LC biotin was
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added to the cells following resuspension in PBS. The mixture was incubated for
30 min at room temperature followed by spinning and washing three times in 1X
PBS. Cells were then diluted and grown in YEPD for 6-8 generations and spun
down, washed with 1X PBS, and resuspended in 10 ml of cold 1X PBS. 50 µl
Streptavidin coated magnetic beads were added to the resuspension and
incubated for 45 min at room temperature. The suspension was washed three
times using 1X cold PBS and purified using LS MACS columns. Isolated cells
were used again for another 1-2 rounds of growth and purification using similar
procedure maintaining cell density within logarithmic growth phase (OD600 < 1.0).

2.7. RNA isolation, cDNA synthesis and quantitative PCR (qPCR)
Total RNA isolation was performed using the Master Pure Yeast RNA Isolation
Kit (Epicentre Biotechnologies, MPY03100) following the manufacturer’s
protocols using the same number of cells for each sample. The DNase I
digestion steps were included in our RNA isolation to obtain a purer sample for
subsequent analyses. The quality of the RNA was confirmed by running RNA
samples on formaldehyde gels . cDNA synthesis was performed using
Transcriptor first strand cDNA synthesis kit (Roche, 04379012001) using strand
specific primers, to be analyzed by subsequent qPCR analyses using LightCycler
480 SYBR green I master mix (Roche, 04887352001) using manufacturer’s
instructions in a LightCycler 480 II PCR machine (Roche). Plotted are the
average and standard error of the mean of three independent experiments.
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P values were determined using Student t-test using Prism 6 software
(GraphPad Software, Inc.). The primers used are listed in Table 2.

Primers
NTS2-1_A
NTS2-1_B
NTS1-2_A
NTS1-2_B
ACT1_RV
qNTS2_1_FW

Purpose
cDNA synthesis of
NTS2 (+) strand
cDNA synthesis of
NTS2 (-) strand
cDNA synthesis of
NTS1 (+) strand
cDNA synthesis of
NTS1 (-) strand
cDNA synthesis of
ACT1 (Crick strand)
qPCR analysis of
NTS2 region

qNTS2_1_RV
qNTS1_2_FW

qPCR analysis of
NTS1 region

qNTS1_2_RV
qACT1_1_FW

qPCR analysis of
ACT1 control

qACT1_1_RV
rDNA_probe2_FW
rDNA_probe2_RV
Chr2_1.FW
Chr2_1.RV
qCARL2_.FW
qCARL2_.RV

Primers to design
probe for Southern
blot against rDNA
(Chr XII)
Primers to design
probe for Southern
blot against Chr II
ChIP primers to check
Mcd1 occupancy at
different regions of
Chr XII

qCARL3_.FW
qCARL3_.RV
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Sequence
5’- GGT AGG TCG AAA CAG AAC
ATG AAA GTT GG -3’
5’- GCT ACT CTC ATG GTC TCA
ATA CTG CC -3’
5’- CAG AGC GGC AAA CAT GAG
TGC TTG TAT AAG -3’
5’- CGT AGT ACA TCT TAC AAC
TCC GCA TAC C -3’
5’- CGG ACA ATT TCT CTT TCA
GCA GTG GTG G -3’
5'- GAG GTA GTT TCA AGG TGA
CAG G -3'
5'- CTC TCA TGG TCT CAA TAC
TGC C -3'
5'- GAG GCT ACT GGG AAG AAG
AAA GAG -3'
5'- CAT CTT ACA ACT CCG CAT
ACC G -3'
5'- GTG ATG GTG TTA CTC ACG
TC -3'
5'- GTA GTC AGT CAA ATC TCT
ACC GGC -3'
5'- CAG GTT ATG AAG ATA TGG
TGC AA -3'
5'- AAA ATG GCC TAT CGG AAT
ACA -3'
5’- GTC TAT ATC GAC GGT AGC
CCA CAC TTG C -3’
5’- CTT GTC GCC CTG TTT CAC
CAC ATC G -3’
5'- CCT GCA TTG TCC TCA TTT
AGT GCT CAG G -3'
5'- TTT GGC AAC GAG ATA GTT
GTG CCC -3'
5'- ATG CCA CCT ACC GAC CAA
CTT TCA -3'
5'- AGA GGT GTT ATG GGT GGA
GGA CAA -3'

qCARL3-N_.FW
qCARL3-N_.RV
qCARC1_positive.
FW
qCARC1_positive.
RV
qCARC_negative.
FW
qCARC_negative.
RV
DSB probe.FW
DSB probe.RV
Probe C.FW
Probe C.RV
Chr1_left.FW
Chr1_left.RV
ChrX_right.FW
ChrX_right.RV
ChrIV_left.FW
ChrIV_left.RV
HOMAT.FW
HOMAT.RV
RAD27.FW
RAD27.RV

5'- TCC ACT TTC AAC CGT CCC
TCC AAA -3'
5'- AGA ATG TCG GCG GCA GTA
TTG AGA -3'
ChIP primers to check 5'- CAG ACG ATA AGT TGA GTA
Mcd1 occupancy at
GCG G -3'
centromeric regions of 5'- GTC CAC TAG GAG ACT CTT
Chr III (+ve control)
GAA C -3'
ChIP primers to check 5'-CAG TGC TAT CGG ATC TAG
Mcd1 occupancy at
GAA G -3'
genomic regions of
5'- GTA TTT GAC GTC TCC GCT
Chr III lacking Mcd1
TTC C -3'
binding (-ve control)
Primers to design
5'- GCC ATT TAC AAA AAC ATA
probe for Southern
ACG -3'
blot against DSB
5'- GGG CCT AGT TTA GAG AGA
probe
AGT-3'
Primers to design
5'- ACA GAT GTG CCG CCC CAG
probe for Southern
CCA AAC TCC -3'
blot against Control
5'- CCT GGA TAT GGA TTC TTC
probe
ACG GTA ACG -3'
Primers to design
5'- GAT TGC CTC TTT TGG GAG
probe for Southern
GTC TGG -3'
blot against Chr I
5'- CCA TCA GGC TCA GAT GAA
TCA TGG GCC -3'
Primers to design
5'- CAC CAC ACC CTG CTT ATT
probe for Southern
AAA GC -3'
blot against Chr X
5'- GAC AGA GGA CTT GTG TGA
CG -3'
Primers to design
5'- CAT TGG GAC AGG TAC TAG
probe for Southern
ATG G -3'
blot against Chr IV
5'- CTA TCT GTC TCT GCT CAG
TGT GG -3'
Primers used for
5'- AGG TAA ATT ACA GCA AAT
multiplex PCR to
AG -3'
analyze HO cutting
5'- AAC AAC AAC CTA GAG TAA
and repair efficiency
TG -3'
5'- ACA TCG CGC AAA TGA AGG
TT -3'
5'- TCA AGT TCC CAG AAA AAC
TG -3'

Table 2: A list of primers used in this study
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2.8. Pulse field gel electrophoresis (PFGE)
Analyses of intact yeast chromosomes were performed using a CHEF DR II
system (Bio-Rad), which is followed by Southern hybridization using probes
against different chromosomes. Yeast cells grown in YEPD or YEPR were
isolated at different time points using the MEP as indicated in the figure or figure
legends. In general, 2X107 cells were used in each well to prepare agarose gel
molds following the manufacturer's instructions (Bio-Rad, Cat#1703593). In brief,
the cell pellet was resuspended in cell suspension buffer and equilibrated at
500C. Plug mold was created using 2% CleanCut agarose in cell suspension
buffer (10 mM Tris, pH 7.2, 20 mM NaCl, 50 mM EDTA), to make a final
concentration of 1% agarose in agarose plug molds. Just before mixing the cells
with agarose, 10 mg/mL Zymolyase (100T) was added, followed by solidification
of the agarose plugs. The agarose plugs were further enzymatically treated with
10 mg/ml Zymolyase in buffer A (10 mM Tris, pH 7.2, 50 mM EDTA) and
incubated at 350C for 2 hours followed by Proteinase K digestion with 1mg/ml
Proteinase K in Proteinase K reaction buffer (100 mM EDTA, pH 8.0, 0.2%
sodium deoxycholate, 1% sodium lauryl sarcosine) at 500C overnight. After
enzymatic digestions, the plugs were washed in wash buffer(20 mM Tris, pH 8.0,
50 mM EDTA) at room temperature and stored at 40C for future use. The
electrophoretic conditions used for my analysis: 3V/cm for 72 h at 14°C with a
300 to 900 sec pulse time and a 1% agarose gel with 0.5X Tris-borate-EDTA
(TBE). The gel was stained with SYBR safe dye (Invitrogen, Cat#S33102) and
visualized using a ProteinSimple Imager (FluorChem E system).
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2.9. Southern blot analysis
Intact chromosomes were resolved in by PFGE on a CHEF agarose gel using
0.5% TBE or digested DNA was resolved in 1% TBE agarose gels. In both
cases, the gels were partially depurinated using 0.25N HCl for 20 minutes at
room temperature and were denatured using denaturing solution (0.5M
NaOH/0.6M NaCl) for 20 minutes at room temperature. The DNA was then
transferred to a nitrocellulose membrane via the capillary method using 2X
SSCPE buffer (to make 1L of 20X concentrate of SSCPE buffer, we combined
140g NaCl, 88g Na-citrate, 35g KH2PO4, 7.4g EDTA, and pH adjusted to 7.2
using NaOH) and UV crosslinked to the membrane. The membrane was then
pre-hybridized using Ultra-hyb buffer (Applied Biosystems, Cat# AM8669) at
420C for 1 hour, followed by hybridization using specific probes against particular
chromosomes or specific DNA sequences at 420C overnight. The probes were
labeled by random prime labeling with 32P (Rediprime II Random Prime Labelling
system, GE, RPN1633) following manufacturer’s protocol. The primer sequences
used for amplifying the probes are listed in the tables for Primers (Table 2).
Specific signal was detected after washing off unbound probe, using 10-15 ml
wash buffer (2X SSPCE, 0.2% SDS), 2 times for 30 minutes each at 65-700C,
using autoradiography.

2.10. Analysis of branched recombination intermediates (stuck DNA
analysis)
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Branched recombination intermediates do not enter the gels during PFGE and
remain in the plug well (stuck DNA). The analysis of branched recombination
intermediate formation has been done for two chromosomes, chr II and chr XII
(rDNA), in both young and old samples. Relative proportions of stuck DNA in the
well during aging was measured by quantifying the signal from Southern blot
using probes against the respective chromosomes. Plotted are the average and
standard error of the mean of three independent experiments. P values were
determined using Student t-test using Prism 6 software (GraphPad Software,
Inc.).

2.11. DSB analysis
Measurement of DSB formation at the rDNA (using restriction digestion by BglII)
was performed according to the following procedure with certain modifications
(137). The procedure of embedding the cells in agarose plugs followed by all
different enzymatic digestions was followed as described and the gel plugs were
loaded into 1% agarose gels, ran in 1XTBE at 30V for 14 hours. The gel was
stained with SYBR safe dye to visualize DNA and used for subsequent Southern
blot using specific probes as mentioned in the figure.

2.12. Chromatin immunoprecipitation (ChIP) and qPCR
Samples for ChIP were collected at different time points of the MEP as indicated
in the figure legends. In brief, cells were cross-linked with 1% formaldehyde for
20 minutes and quenched by addition of 1M glycine to the final concentration of
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125 mM. Cells were lysed using lysis buffer (140 mM NaCl, 50 HEPES pH 7.5, 1
mM EDTA, 0.1% deoxycholic acid, 1% Triton X-100) in the presence of a
protease inhibitor cocktail (protease inhibitor cocktail set IV, Calbiochem, cat#
539136) using glass beads at 40C for 10 minutes in a bead beater and then kept
on ice for 15 minutes. The extract was removed, transferred to a fresh tube,
followed by shearing of the chromatin by sonication using a Branson 350 Sonifier
(Output: 2, Timer: Hold, Duty cycle: Constant, 100% power). The samples were
centrifuged at maximum speed at 40C and for 5 minutes, 2 times to separate
supernatant from the cell pellet. A small portion of supernatant (50 µl) was mixed
with 30 µl ChIP elution buffer (50 mM Tris-HCl pH 7.5, 10 mM EDTA, 1% SDS) to
be used as input controls and immunoprecipitation was performed with the rest of
the supernatants using specific antibody. For immunoprecipitation for each
sample, 10 µl Dynabeads Protein A (Invitrogen, 100-02D) pre-mixed with 2 µl
antibody was added to the cell lysate to incubate at 40C overnight. The following
day beads were washed using magnetic stand in the following buffers: two times
washing in cold Lysis buffer (0.1% deoxycholic acid, 1mM EDTA, 50mM HEPES
pH 7.5, 140mM NaCl, 1% Triton X-100), two times washing in cold Lysis buffer500 (0.1% deoxycholic acid, 1mM EDTA, 50mM HEPES pH 7.5, 500mM NaCl,
1% Triton X-100), two times washing in cold LiCl detergent (0.5% deoxycholic
acid, 1mM EDTA, 250mM LiCl, 0.5% NP-40, 10mM Tris pH 7.9) and once with
cold 1X TE buffer. Following the washes, for each IP sample 80 µl of ChIP
elution buffer was added to the beads. After elution step, 20 µl 20 mg/ml Pronase
was added to both 80 µl of Input and IP samples to incubate in a PCR cycler for
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the following program (420C for 2 hours; 650C for 8 hours; 40C, hold) to reverse
crosslink and to digest proteins. The DNA was then purified using MinElute DNA
purification kit (Qiagen, 28004). Quantitation of the DNA sequences in the input
samples and immune-precipitates was performed via real-time qPCR analyses
using LightCycler 480 SYBR green I master mix (Roche, 04887352001) using
manufacturer’s instructions in a LightCycler 480 II PCR machine (Roche). A
polyclonal antibody against rabbit hemagglutinin (HA) (Abcam, ab9110) was
used to measure the occupancy of Mcd1, a cohesion subunit, at different regions
around the rDNA locus and control regions. Plotted are the average and standard
error of the mean of three independent cultures for each experiment. P values
were determined using Student t-test using Prism 6 software (GraphPad
Software, Inc.). The primers used are listed in Table 2.

2.13. Western blot analysis
Total protein extracts were isolated by boiling samples (same cell number for
each sample) in 2X sample buffer (0.06M Tris-HCl, pH 6.8, 10% glycerol, 2%
SDS, 5% 2-mercaptoethanol, 0.0025% bromophenol blue) prior to loading gels.
Samples were resolved using 4-20% Criterion TGX precast gels (Biorad, 5678095) using 80 volt for 2 hours, and then transferred to nitrocellulose membrane
using 450 mAmps for 45 minutes at cold room. The membrane was blocked
using 5% non-fat milk diluted in 1X TBS with Tween 20 (TBST) for 30 minutes,
followed by incubation in presence of primary antibody in TBST for 1 hour at
room temperature, and washing the membrane with 1X TBST three times, 10
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minutes each. After the washes incubation with secondary antibody in TBST was
done, 1 hour at room temperature, followed by three washes with 1X TBST, 10
minutes each. Membranes were then developed using either Amersham ECL
western blotting detection reagent (GE) or Immobilon Western HRP substrate
(Millipore). Dilutions for primary and secondary antibodies used are listed in
Table 3.

2.14. Cohesion assay (GFP two spot analysis)
To investigate sister-chromatid cohesion, strains where the LacO array is
inserted into rDNA (RDN) or telomere (TEL) expressing LacI-GFP fusion protein
were used (133). Aged cells were collected following two rounds of biotin affinity
sorting. The exponential growth of the culture was maintained by limiting the cells
to going through ~6 doublings before each round of sorting. Cell surface was
labeled with Ez-link Sulfo-NHS–LC-LC biotin (Thermo-scientific) with a 30 minute
long pulse of 3 mg/ml concentration biotin in YPD, were washed 3 times in 1X
PBS, followed by 10-12 hrs of exponential growth in YPD media and affinity
purified following incubation with streptavidin-coated magnetic beads (Miltenyi
Biotec, NC9821945) using LS MACS column (Miltenyi Biotec) using the
procedure as previously described (138). Cells at G2/M phase (large budded
cells) were scored for a single fluorescent GFP dot (maintenance of cohesion)
versus two separated fluorescent GFP dots (loss of cohesion) as visualized by
fluorescence microscopy. More than 100 cells were counted for each sample.
Plotted are the average and standard error of the mean of three independent
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experiments. P values were determined using Student t-test using Prism 6
software (GraphPad Software, Inc.).

2.15. Repair assay using MMS
For the repair assay, biotinylated cells were grown in YEPD media according to
the MEP method and samples were collected before inducing any damage. For
damage induction, 0.07% Methyl Methanesulfonate (MMS) (Sigma-Aldrich,
129925-5G) was used for 30 minutes followed by washing the cells in fresh YPD
media thrice. For analyzing post-damage repair kinetics samples were collected
3 and 6 hours after washing out the MMS. All the samples collected at different
time points were subject to magnetic biotin-streptavidin purification as described
previously in the cold room. For old samples, damage induction with MMS was
started at 22 hours into growing the cells following MEP procedure so that the 6
hours repair time course was finished within 30 hours of the start of the MEP. For
each time point, 2x107 cells were collected and processed for making DNA plugs
in agarose for subsequent PFGE analysis.

2.16. Immunofluorescence (IF) analysis
Samples for IF analysis were collected following the MEP procedure in 2L
cultures. Cells were fixed with 4% formaldehyde followed by spheroplasting using
10 mg/mL Zymolyase (100T) (USBiological, Z1004) for 40 to 60 minutes.
Spheroplasting was confirmed visually under the microscope. Spheroplasts were
harvested and applied to a poly-lysine coated microscope slide. The cells were
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permeabilized using methanol and acetone followed by blocking with 3% PBSBSA and incubation with primary and appropriate fluorescent secondary
antibodies. The antibodies used are listed in Table 3.

Antibody (animal source)
HA (Rabbit)

Source (Catalog #)
Abcam (ab9110)

H3-C (Rabbit)
Rfa1 (Rabbit)
Rfa2 (Rabbit)
Rad51 (Rabbit)
Rad52 (Rabbit)
Rad53 (Mouse)

Abcam (ab1791)
Brush et al., NAR, 2000
Brush et al., NAR, 2000
Abcam (ab63798)
Santa Cruz (sc-50445)
Fiorani et al., Cell cycle,
2008
LSBio (LS-C155765)
AbD Serotec (MCA78G)
Abcam (ab15083)
Promega (W4021)
Promega (W4011)
Sigma (A5795)
Invitrogen (A-11037)

Mre11 (Rabbit)
α-Tubulin (Rat)
phospho-H2A S129 (Rabbit)
Anti-mouse, HRP
Anti-rabbit, HRP
Anti-rat, HRP
Anti-rabbit IgG (H+L) Alexa
flour 594

Dilution
1:4000 (WB);
2 µl (per ChIP)
1:5,000 (WB)
1:2,500 (WB)
1:2,500 (WB)
1:5,000 (WB)
1:500 (WB)
1:100 (WB)
1:1,000 (WB)
1:1,000 (WB)
1:10,000 (IF)
1:10,000 (WB)
1:10,000 (WB)
1:4,000 (WB)
1:1,000 (IF)

Table 3: A list of antibodies used in this study

2.17. PCR analysis of HO cutting and repair efficiency
Following collection of samples at each time point of the repair time-course
experiment, yeast cells were collected by centrifugation and genomic DNA was
isolated as described earlier. A multiplex PCR assay was done following
published protocol (139) using HOMAT and RAD27 (as a control) primers (140).
PCR products were resolved by 1.5% agarose gel electrophoresis. The gel was
stained with SYBR safe dye and visualized using a ProteinSimple Imager
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(FluorChem E system). While the PCR product generated by RAD27 primers is
expected to be ~1.4 Kb, HOMAT primer pairs generated a MATa product with the
size of ~1.1 Kb, and a MATα product with the size of ~1.2 Kb. Quantification of
the relative amount of MATa or MATα products (normalized to control) during HO
cutting and repair assay was performed using AlphaView software available with
the ProteinSimple Imager.
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CHAPTER 3: ROLE OF RIBOSOMAL DNA (rDNA)
INSTABILITY IN REGULATION OF LIFESPAN IN
BUDDING YEAST
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3.1. Introduction and Rationale
As described in Chapter 1, the ribosomal DNA (rDNA) locus is a unique
locus in the eukaryotic genome. It is located within the nucleolus and is crucial to
maintain critical housekeeping functions for the cells, as well as other extracoding functions that have been emphasized more recently (33, 102). It is also
one of the highly unstable regions of the genome (141). rDNA instability has long
been implicated in lifespan determination in yeast and Drosophila (25, 104), but
most of the evidence was circumstantial. For example, characteristic aging
phenotypes in budding yeast are nucleolar enlargement and fragmentation that
implicated that there are changes to the rDNA locus during aging (105, 112). At
the same time, even after it was unclear whether ERCs are the cause of aging or
simply the by-products of rDNA instability (112), increased accumulation of ERCs
during aging only underscores the inherent instability of this locus that worsens
with age. Furthermore, increased LOH at the rDNA locus of the daughters of
aged yeast cells also serve as an indirect indicator of increased rDNA instability
with aging (105, 142). Interestingly, the age-induced hyper-recombinational state
of the rDNA is not solely restricted to budding yeast but has also been found in
adult solid tumors (143). Of note, aging is the highest risk factor for cancer. All
these evidence correlate and potentially implicate changes in rDNA instability to
aging. However, it is yet to be addressed directly if there is indeed increased
rDNA instability in aged cells and whether rDNA instability affects lifespan as
predicted by the “rDNA theory of aging”. As the use of the MEP now enables us
to uncover specific events in a truly aged population of yeast cells, which are at

58

or beyond their median lifespan, it is possible to address what happens at the
rDNA locus during the aging process.
Previously our lab revealed chromatin structure as a major modulator of
aging in yeast and provided evidence of drastic histone protein loss from different
regions of the genome including the rDNA locus during aging (38). A more open
chromatin structure with aging is likely to provide inappropriate access to the
genome, leading to loss of genomic integrity affecting all the genomic regions,
but may be affecting the fragile genomic regions like the rDNA even more. Our
earlier study, which showed massive nucleosome loss during replicative aging
coupled with drastic transcriptional upregulation and increase in genomic
instability, also provided evidence of the involvement of the rDNA in increased –
intra and –interchromosomal translocation and amplifications of the chromosome
segment distal to the rDNA during aging (40). Thus, the objective of the first part
of my project is to test the ‘rDNA theory of aging’ to determine whether there is
increased rDNA instability during yeast replicative aging and if so, to characterize
the mechanism behind it. As rDNA is universally present in all eukaryotes and
most of the fundamental biological pathways are well conserved among
eukaryotes, it has the potential to serve as a more common lifespan determinant
(102). Altogether, this study has the potential to be applicable to the replicative
aging of stem cells, which are mitotically dividing cells, unlike most of the adult
tissues in multicellular eukaryotes where cells are maintained in a non-dividing
state.
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3.2. Results

3.2.1. Non-coding RNA transcription is highly induced from NTS1 and NTS2
in the intergenic spacer region of the rDNA locus in old cells
The rDNA locus in budding yeast is located in a single cluster at the right
arm of chromosome (chr) XII, consisting of approximately 150 tandem repeats of
rDNA units, as described earlier (Fig. 6). Within each individual rDNA repeat
there are non-transcribed spacer regions 1 and 2 (NTS1 and NTS2). These
regions are silenced via the recruitment of the Sir2 containing complex known as
RENT (regulator of nucleolar silencing and telophase exit) (144). During the
course of our previous RNA-seq analyses during yeast replicative aging (40), we
noted that transcription from the NTS1 and NTS2 regions was the most induced
out of all the yeast genes during aging. Given that transcription of the NTS1 and
NTS2 non-coding RNAs has never been observed in wild type yeast previously, I
validated the RNA-seq results using strand specific reverse transcription PCR.
Using aged cells isolated using the MEP that are 25 or more generations old on
average, I found 21-87 fold transcriptional induction from NTS1 when normalized
to ACT1 transcription and 18-34 fold induction from NTS2 depending on which
strand was being examined in old cells in comparison to their young counterparts
(Fig. 8A, B). Strand-specific transcript analysis revealed induction of non-coding
RNA from both Watson (+) and Crick (-) strands at NTS1 and NTS2 consistent
with their having bidirectional promoters (113, 145). Transcriptional upregulation
has been observed from all genes in the yeast genome during replicative aging
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Figure 8: Transcriptional up-regulation from non-transcribed regions of
rDNA during aging. (A, B) Strand-specific qRT-PCR analysis to examine the
fold increase in non-coding RNA levels in old cells from both Watson (+) and
Crick (-) strands of (A) NTS1 and (B) NTS2 regions of rDNA in comparison to
young cells. RNA levels were normalized to ACT1 transcript levels in both young
and old cells before normalizing to 1 for young cells in each case. Average and
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standard error of the mean of three replicates are plotted. Asterisk (*) indicates
significant changes in old from young (p<0.05), as determined by the Student’s ttest. (C) Levels of ACT1 strand-specific transcription from same number of young
and old cells. Average of two independent replicates are plotted here.
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(40). Therefore, before using the ACT1 transcript as our normalization control, I
determined the level of ACT1 transcription from same number of cells in both
young and old cells, and found that the ACT1 transcript levels were slightly
higher in aged cells (Fig. 8C). These results validate that transcriptional silencing
is lost from both NTS1 and NTS2 during aging. As mentioned before, the rDNA
locus contains diverse genomic elements and activities of all three RNA
polymerases (RNA Pol I, II, and III) are observed at this locus (146). An earlier
study found RNA polymerase I transcription is inversely proportional to ncRNA
production at the rDNA locus, suggesting that RNA polymerase I activity may act
to silence ncRNA production at this locus (146). However, when I compared the
levels of 25S and 18S rRNA level as an indication of RNA polymerase I activity in
young and old cells, I did not find any significant difference between them (Fig.
9A, B), indicating that the increased NTS1 and NTS2 transcription observed
during aging is not a reflection of loss of RNA polymerase I-mediated regulation. 	
  

3.2.2. Cohesin occupancy is reduced from the rDNA region during aging
Transcription from the bidirectional E-pro promoter of NTS1 in yeast
deleted for SIR2 has been reported to promote dissociation of cohesin from the
rDNA locus to regulate recombination (113). Since I observed increased noncoding RNA produced from the rDNA region during aging as a consequence of
histone loss during aging (40), I asked whether this transcription displaces
cohesin from the rDNA during aging. I epitope tagged Mcd1, the limiting subunit
of the cohesin complex (147) with HA and measured cohesin occupancy by
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Figure 9. No significant difference in RNA Polymerase I (Pol I)
transcriptional activity is observed during aging. (A, B). Pol I transcriptional
activity as observed from the levels of 25S and 18S rRNA levels. (A) Results
from three independent replicates are shown. (B) Ten fold serial dilutions of each
samples to illustrate the differences between young and old samples from three
independent replicates. The same number of cells are analyzed for young and
old cells.
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chromatin immunoprecipitation (ChIP) during aging. I examined two known
cohesion associated regions (CAR) within different rDNA repeats during aging
(CARL3, CARL3-N) and one region outside rDNA locus but still located at the
right arm of chromosome XII (CARL2) (Fig. 10A). As a positive control, I used
the centromeric region of chromosome III and a cohesin-depleted region of
chromosome III (Chr III: 309955 to 310355) as a negative control (148). Mcd1
occupancy was significantly lower in aged cells within the rDNA in comparison to
young cells (Fig. 10B). However, there was also a similar degree of cohesin
occupancy reduction at a different cohesin binding site of chromosome XII
outside of rDNA locus and also at the centromeric region of chromosome III in
old cells (Fig. 10B), indicating that reduced cohesin occupancy during aging
extends beyond the rDNA locus.

3.2.3. Cohesion is lost not only from the rDNA locus, but also globally
during aging
In order to determine whether the reduction of cohesin occupancy from
different genomic locations that I observed during aging (Fig. 10) is functionally
relevant, I measured cohesion during aging using a functional assay. I visualized
cohesion at the rDNA and telomere by observing Lac repressor-GFP localization
in G2/M phase cells in strains where the lacO array was inserted into either the
rDNA or telomere (33). When the sister chromatids are cohesed, there is a single
GFP signal per cell, while cohesion loss gives rise to two GFP spots in each cell
(33) (Fig. 11A). I found that the percentage of separated sister chromatids was
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the right. (B) Quantification of loss of cohesion at rDNA and telomeric regions
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from young (p<0.05), as determined by the Student’s t-test.
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significantly higher at both the rDNA and telomere in older cells (Fig. 11B). As
such, there is a significant loss of cohesion with aging at the rDNA and other
regions of the genome.

3.2.4. Cohesin displacement from the rDNA does not correlate with noncoding RNA transcription
I further examined the relationship between non-coding RNA expression
from the rDNA and cohesion, as it relates to longevity in the rDNA theory of aging
(112). Previously, when transcription was induced from the galactose-inducible
bidirectional Gal1/10 promoter (Gal-pro) that was inserted in place of the native
E-pro promoter in the NTS1 locus (Fig. 12A), it increased rDNA instability and
reduced lifespan (149). On the contrary, transcription inhibition from Gal-pro by
addition of glucose reduced rDNA instability and increased lifespan (149). Using
the same strains but with HA-tagged Mcd1, I asked whether induction of noncoding transcription from NTS1 is sufficient to displace cohesin. I found that
neither repression nor induction of NTS1 transcription by Gal-pro had a
significant effect on cohesin occupancy at CARL2 (Fig. 12). Meanwhile, both
repression and induction of NTS1 transcription by Gal-pro caused a significant
reduction of cohesin occupancy at CARL3 and CARL3-N, two intergenic noncoding regions of the rDNA within other copies of the rDNA repeat (Fig. 12).
Noteworthy, repression of NTS1 transcription led to the greatest loss of cohesin
occupancy at these sites (Fig. 12). As such, while NTS1 transcription may limit
replicative lifespan (149), this is independent of its effect on cohesin occupancy
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induction of Gal-pro by galactose or repression by glucose. Data shown here was

69

normalized to a positive control region and then to E-pro. Average of two
independent experiments are plotted here. Error bars indicate experimental
variations.
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at the rDNA. Our findings disagree with the previously made conclusion that
NTS1 transcription leads to displacement of cohesin while NTS1 repression
leads to maintenance of cohesion (113).

3.2.5. The majority of the non-coding RNA in old cells arises from ERCs
Since I found no correlation between NTS1 transcription and cohesin
occupancy (Fig. 12), I asked whether the non-coding RNAs produced during
aging come from the rDNA on chromosome XII or whether they are expressed
from the ERCs. I measured the non-coding rDNA transcript levels in wild type
yeast and a fob1∆ mutant, where ERCs accumulate to a much lower degree
during aging (110). Because the fob1∆ mutant cells live longer, we isolated cells
with a mean age of ~30 replicative divisions and found that deletion of FOB1
caused an 8-fold reduction in NTS1 transcription, and a 30 fold reduction in
NTS2 transcription, in old cells (Fig. 13A, B). As such, I conclude that the
majority of NTS1/2 transcription in old cells comes from the ERCs and not from
chromosome XII.

3.2.6. Expression of Mcd1, the limiting sub-unit of cohesin complex, is
reduced during aging
All of our evidence so far suggested that the loss of cohesin and cohesion
during aging was not related to non-coding transcription from the rDNA. Rather I
found the cohesion loss during aging extends in other genomic regions as well,
indicating a more global change. Therefore, I asked whether the protein level of
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contributed by extra-chromosomal rDNA circles (ERCs). Strand-specific
qRT-PCR analysis to examine the fold increase in non-coding RNA levels in old
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cohesin components is reduced during aging. Loading total protein samples from
equal numbers of cells, I found that the level of the rate limiting Mcd1 subunit of
cohesin was drastically reduced during aging (Fig. 14A). I also observed a very
similar decrease when I analyzed Mcd1 levels during aging when I normalized
sample loading to equal DNA content (Fig. 14B). Therefore, I conclude that a
lower protein level of Mcd1 is the likely explanation for the global cohesion defect
in old cells.

3.2.7. The rDNA locus undergoes unequal recombination and repeat
number variation during aging
Increased NTS1 and NTS2 transcription (Fig. 8) together with loss of
cohesin occupancy (Fig. 10) at the rDNA region during aging, and the already
existing correlation of rDNA with aging prompted us to ask if there is unequal
recombination at rDNA in old cells resulting in rDNA repeat
expansion/contraction. I compared the length of chromosome XII in young and
old cells via pulse-field gel electrophoresis (PFGE) followed by Southern blot with
an rDNA specific probe (Fig. 15A). Chromosome XII in aged cells showed
variability in its size with two main populations, one having gained rDNA repeats
and one having lost rDNA repeats. Meanwhile young cells showed only one band
that corresponds to chromosome XII, indicating uniform rDNA locus length in the
majority of young cells. I asked at what age the rDNA locus started showing
variability, and found that the rDNA repeat number variability starts arising from
middle age (~14-15 divisions) and progressed with the age (Fig. 15B). Of note,
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Figure 15. The rDNA locus undergoes unequal recombination with age. (A)
Analysis of intact yeast chromosomes by PFGE from young and old yeast cells.
Left panel shows staining pattern of chromosomes by SYBR safe. Right panel
shows Southern hybridization using a Chr XII (rDNA) specific probe. The rad52∆
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while the rDNA probe displayed chromosome XII specificity in young cells, it
hybridized to seemingly all other chromosomes in old cells, in addition to
chromosome XII (Fig. 15A, B). Taken together with our previous observation of
rDNA sequences fused to other chromosomal sequences apparent from deep
sequencing of the old genome (40), these southern blots suggest that small
rDNA repeat fragments insert into other yeast chromosomes during aging.

3.2.8. Formation of branched recombination intermediates increases from
rDNA during aging
While insertions of rDNA repeats into other chromosomes, chromosomal
amplifications having break points at the rDNA (40) and altered chromosome XII
sizes (Fig. 15A) in old cells are likely to be the product of inaccurate repair of
DSBs within the rDNA, I asked whether I could find direct evidence of rDNA
recombination actively occurring in old cells. Recombination intermediates are
unable to enter the PFGE gel, leading to their being stuck in the wells. An
analysis of ‘stuck DNA’ in the wells has been used to show that there are more
rDNA recombination intermediates in mother cells (~3-4 generations) compared
to daughter cells (~0-1 generations) (104). By comparing daughters to much
older mothers (25 or more generations), I found that chromosome XII from old
mothers was 4 times more likely to be stuck in the well compared to chromosome
II from old mothers (Fig. 16A, B), indicating that old cells have more rDNA
recombination intermediates.
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Figure 16. Increased rDNA recombination products is observed in old cells.
(A) Stuck DNA analysis in the gel wells for Chr XII (rDNA) and Chr II. Intact yeast
chromosomes were analyzed by PFGE. For each chromosome (XII and II), the
left panel indicates the staining pattern of chromosomes by SYBR safe, the right
panel shows Southern hybridization using the indicated probe. Closed triangles
indicates stuck DNA in the well. The same number of cells were analyzed in each
lane of the gel. (B) Quantification of A is shown. The signal of the chromosomes
stuck in the well for respective chromosomes was quantified and plotted as the
relative intensity of stuck DNA in old cells compared to young cells. Three
independent replicates are plotted here and error bars represent standard error
of the mean. Asterisk (*) indicates significant changes in band intensity from chr
II to chr XII (p<0.05), as determined by the Student’s t-test.
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3.2.9. DNA double-strand break formation at the rDNA locus does not
increase during aging per se
Next, I asked directly whether old yeast cells have more DSBs within the
rDNA locus. To do this, I performed southern analysis with the BglII restriction
enzyme that cuts proximal to the rDNA and used southern blotting to detect the
intact DNA fragment and smaller chromosomal fragments due to DSBs at the
replication fork block (RFB) site (137) (Fig. 17A). While I could detect DNA
fragments that are due to DSBs around the RFB in young cells, their abundance
was not significantly increased in aged cells (Fig. 17B). The evidence taken
together suggests that DSBs at the RFB within the rDNA accumulate with the
same frequency in old and young cells, but that old cells are more likely to repair
these DSBs using unequal sister recombination or inaccurate fusion to other
chromosomes.

3.3. Conclusions
According to the ‘rDNA theory of aging’, the rDNA locus plays a central
role in regulating lifespan, where this already fragile region becomes even more
unstable with the progression of age and acts as an internal sensor to gradually
lengthen the cell cycle and finally induce senescence (112). This theory further
emphasizes that ERCs are the by-products of rDNA instability (112), as opposed
to the idea of ERCs being the cause of aging in budding yeast, as proposed
earlier (32). Increased transcription from the intergenic regions of the rDNA locus
due to loss of Sir2-mediated silencing has been proposed to specifically displace
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or control probe, as indicated. Asterisks (*) indicate DNA fragments generated
potentially from DSBs near the RFB, while arrows indicates control fragments
resulting from restriction digestion by BglII and no DSB at RFB.
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cohesin from the rDNA (113) leading to loss or gain of rDNA repeats, rDNA
instability and aging. In my findings described in this chapter by analyzing the
events in the true population of aged cells, I have uncovered that rDNA indeed
becomes more unstable with age but is acting through a different mechanism
than previously assumed. I observed massive increases in non-coding RNA
(ncRNA) transcription from the intergenic spacer regions of the rDNA locus of
aged cells (Fig. 8). However, I found the majority of this ncRNA transcription
actually was contributed by ERCs by comparing WT cells with a mutant (fob1∆)
that is known to accumulate fewer ERCs during aging (110) and has a longer
lifespan (Fig. 13). As such, the idea that enhanced transcription from the noncoding regions of the rDNA in old cells is what displaces cohesion to lead to
rDNA instability and aging is likely to be inaccurate.
Furthermore, I did not find any correlation between induction of noncoding RNA transcription from the rDNA locus and cohesin occupancy, as even
forced transcriptional induction of non-coding RNAs from the rDNA locus in
young cells did not displace cohesin from the rDNA (Fig. 12). This further
indicates that Sir2-mediated silencing of the non-coding spacer regions of the
chromosomal rDNA locus is irrelevant to influencing replicative aging. However,
my results indicate that the rDNA locus undergoes unequal sister-chromatid
recombination, which starts around middle age and progresses with age (Fig.
15). I also find that more rDNA recombination intermediates accumulate with
aging (Fig. 16), which undeniably confirms the proposed increase in rDNA
instability during aging. While trying to find the reason behind this repeat number
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change of rDNA copies in old cells, I did not observe any increase in DSB
accumulation at the rDNA locus in replicatively old cells per se compared to
young cells (Fig. 17), which probably implies that old cells still repair these DSBs
at the rDNA but in an inaccurate manner.
Noteworthy, I observed a significant reduction in cohesin occupancy at the
rDNA locus during aging (Fig. 10). However, I also found this loss of cohesin
occupancy and loss of cohesion extended beyond the rDNA locus to other
genomic sites such as, telomeres and centromeres during aging (Fig. 10, 11).
This defect is most likely attributed to the reduced levels of the limiting cohesin
protein Mcd1, which is due in turn to reduced protein synthesis of Mcd1 during
aging (Tyler lab, unpublished observation) (Fig. 14). Taken together, I conclude
from this part of my study that the rDNA locus becomes unstable with age,
potentially contributing to limiting the replicative lifespan. However, this study
does not rule out the contribution of the increased accumulation of ERCs to
aging, which may be responsible for possible titration and sequestration of
different repair factors away from the genome (see next chapter). The loss of
cohesion observed with aging would explain finally the reason behind the
accumulation of ERCs during aging, as cohesion is essential for equal sister
chromatid recombination between the rDNA repeats. However, the effect
cohesion loss supposedly should have larger implications during aging than only
affecting the rDNA locus. Given the role of cohesin in promoting DSB repair, loss
of cohesion may affect global genomic instability to limit replicative lifespan in
yeast. Furthermore, loss of cohesion during aging is also likely to lead to
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chromosomal loss and aneuploidy, which would also have a negative
contribution to replicative lifespan.
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CHAPTER 4: MECHANISTIC INSIGHTS INTO
UNDERSTANDING INCREASED DNA LESION
FORMATION DURING REPLICATIVE AGING
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4.1. Introduction and Rationale
As discussed in chapter 1, genomic instability serves as a primary
hallmark of aging (9). It is a well-conserved aging factor across many different
organisms (150, 151). As mentioned earlier, the implication of genomic instability
during aging is further strengthened by the evidence that certain human
premature aging diseases are characterized by a defect in DNA repair genes
(121-123, 152). Also, mutations of several repair proteins in yeast result in
shortening of replicative lifespan (153). However, it is yet to be demonstrated
whether enhanced DNA repair causes extension of lifespan. Of note, a very
interesting correlation analysis comparing species with extreme differences in
lifespan suggested that the longer-living species have higher expression of DNA
repair genes and superior genome maintenance versus the short-lived species
(73).
Our group previously demonstrated drastic loss of histone proteins during
replicative aging in yeast, which also serves as a cause of aging in yeast (38).
This loss of histones is a more generalized phenomenon and conserved also in
multicellular eukaryotes as this has been observed during in vitro replicative
aging of human fibroblasts (48). As mentioned previously, loss of histones during
aging implies a more open chromatin conformation with less tight regulation for
all the biological processes that require access to DNA. Given that chromatin
structure is extremely critical to maintain genomic integrity, it is possible that an
open chromatin structure observed during aging would give rise to increased
genomic instability. We found that this is indeed the case during aging. We

85

showed significant increases in DNA breaks and associated changes resulting in
increased genomic instability during yeast replicative aging (40). Building on
these observations, an interesting and challenging goal is to determine the
molecular mechanism behind the increase in DNA lesions observed during yeast
replicative aging. Utilizing the budding yeast RLS model system, I sought to
analyze the possible causes of loss of genomic integrity with aging. Using the
replicatively aged yeast cells, it is possible to determine whether there is a defect
in DNA repair per se during yeast replicative aging and whether a decline in DNA
repair efficiency contributes to the high level of genomic instability and DNA
lesions observed during aging.

4.2. Results

4.2.1. Increased chromosomal instability proportional to chromosome
lengths is observed during aging
My results showed clear evidence of chromosomal fragmentation in old
cells, apparent from the smearing of the chromosomal signals for all
chromosomes from old cells upon total DNA staining in all our PFGE analyses. If
the aging genome experiences random DNA breakage, I predict that the loss of
intactness of the chromosomes would be inversely proportional to chromosome
length, with the longest chromosomes becoming least intact with age. From
quantitation of total DNA staining, I did indeed observe that the intactness of
chromosomes in old cells was inversely proportional to their length (because we
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Figure 18. The aging genome accumulates random damage. (A) Analysis of
intact yeast chromosomes by PFGE from young and old yeast cells. Left panel
shows staining pattern of chromosomes by SYBR safe. (B) Right panel indicates
the quantification of the chromosomal band intensities as measured from the
SYBR safe stained gel, following normalization of signal intensity of young cells
to 100% for each chromosome or group of chromosomes (both for single
chromosomal band or band corresponding to multiple chromosomes as
indicated). Average and standard error of mean of three replicates are plotted.
Asterisk (*) indicates significant changes in old from young (p<0.05), as
determined by the Student’s t-test.
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see multiple bands of chromosome XII indicating increased rDNA instability, we
excluded chromosome XII from this analysis) (Fig. 18A, B). To more accurately
examine this relationship, I performed PFGE followed by southern blot analysis
of a long chromosome (chromosome 4, 2nd longest in the yeast genome), a
middle sized chromosome (chromosome 10) and the smallest chromosome
(chromosome 1). While the loss of intactness of chromosomes was least for the
smallest chromosome in old cells, the longer the chromosome was, the greater
was the loss of intactness observed during aging (Fig. 19A, B). These data
indicate that there is DNA double-strand break accumulation along the length of
all chromosomes in old cells.

4.2.2. Global chromosomal instability in old cells is proportional to rDNA
instability
To determine whether the global chromosomal instability was somehow
related to the rDNA instability, we compared the intactness of chromosomes
during aging between wild type yeast and a fob1∆ mutant which has much less
DSBs at the RFB within the rDNA (110). With the fob1∆ mutant, we observed a
similar trend of chromosomal intactness inversely proportional to chromosome
length in old cells by SYBR safe staining, but the general chromosomal
intactness was greater in similarly aged fob1∆ mutants in comparison to wild type
cells (Fig. 20). In order to confirm this finding, we performed southern analysis
for three chromosomes of different lengths in wild type and fob1∆ mutant yeast,
comparing the same number of same age cells. In agreement with our previous
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Figure 19: Increased chromosomal instability proportional to chromosome
length is observed during aging in WT cells. (A) Analysis of intact yeast
chromosomes by PFGE from same numbers of young and old WT yeast cells
followed by Southern hybridization using specific probes against three
chromosomes of different sizes: long (Chr IV), middle-sized (Chr X) and short
(Chr I). In each case, left panel shows staining pattern of chromosomes by SYBR
89

safe and right panel shows Southern hybridization using the indicated probe. (B)
Quantification of A is shown. The graph shows percent loss of band intensity in
aged cells measured from Southern blots of respective chromosomes, following
normalization signal intensity of young cells to 100% for each chromosome.
Average and standard error of mean of three replicates are plotted. Asterisk (*)
indicates significant changes in old from young (p<0.05), and also significant
changes in chromosomal band intensities between chromosomes of different
lengths in old cells as determined by the Student’s t-test.
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Figure 20. rDNA instability appears to promote global genomic instability.
(A) Analysis of intact yeast chromosomes by PFGE from same numbers of young
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replicates are plotted here. (C) Analysis of intact yeast chromosomes by PFGE
from same numbers of young and old yeast cells from both WT and fob1∆ strains
followed by Southern hybridization using specific probes against three
chromosomes, Chr IV, Chr X and Chr I. In each case, left panel shows staining
pattern of chromosomes by SYBR gold and right panel shows Southern
hybridization using the indicated probe.
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finding, we found the chromosomal intactness was better maintained in the fob1∆
mutant when compared to wild type for every chromosome, and that the loss of
chromosome intactness in old cells was again more pronounced in longer
chromosomes than smaller ones (Fig. 20). These data indicate that rDNA
instability is proportional to, and at least in part likely responsible for, loss of
global chromosomal stability in old cells.

4.2.3. DSB repair is significantly impaired in old cells
We observed previously that replicatively aged cells accumulate DNA
breaks (40) and above we found that during the course of aging, DNA damage
randomly accumulated across the genome (Fig. 18, 19). This raises the question
of whether there are more DSBs in old cells because there is less repair and / or
more DNA damage. In order to determine directly if there is a defect in DSB
repair efficiency in aged cells, I attempted to take advantage of an inducible
system of DSB induction at a specific site, that is HO endonuclease-inducible
DSB formation at the MAT locus of budding yeast (139). The expression of HO
endonuclease is under the control of galactose-inducible and glucose-repressible
promoter. Therefore, it is possible to specifically induce a DSB at the MAT locus
at any given time by the addition of galactose and follow the repair kinetics after
the addition of glucose to repress endonuclease expression. Using semiquantitative multiplex PCR analysis, it is possible to measure the degree of HO
cutting and repair efficiency over the time course, which measures DSB repair
kinetics. Utilizing the MEP strain carrying inducible HO endonuclease, I
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Figure 21. The HO endonuclease is ineffective in inducing DSBs in old
cells. (A) Schematic diagram of the experiment using HO endonuclease for
damage induction to follow repair dynamics in young and old cells. (B) PCR
analyses of HO cutting and repair dynamics in young and old cells. While young
cells show HO sensitivity and efficient cutting and repair dynamics, HO
endonuclease activity is undetectable in old cells.
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measured the HO cutting and repair dynamics in young and old cells following a
repair time-course (Fig. 21A). While the young cells showed efficient cutting and
repair dynamics as seen by loss of the MAT alpha PCR product and appearance
of the MATa PCR product which is a consequence of DSB induction and DSB
repair at the MAT locus, respectively. However, I could not achieve detectable
DSB induction at the MAT locus in aged cells, reflected in the constant levels of
the MAT alpha PCR product (Fig. 21). The most likely reason for this is that there
is a defect in HO endonuclease protein synthesis, as we have recently observed
a global defect in protein synthesis during aging (Tyler lab, unpublished
observation).
Therefore, in order to examine if DSB repair is defective in old yeast cells,
I utilized a different approach and induced global DSBs in young and old yeast
cells using the alkylating agent methyl methane sulfonate (MMS), and compared
their ability to repair the DSBs by resolving intact yeast chromosomes using
PFGE. In young cells, MMS treatment induced smearing of the otherwise intact
chromosome bands that is indicative of DSBs (Fig. 22). However, following
removal of MMS from the media, within 6 hours young cells repaired most of the
DNA breaks and the intactness of the chromosomes was restored to the level
observed before damage induction (Fig. 22). In contrast, there was a clear defect
in old cells in the ability to re-establish intact chromosomes following MMS
removal (Fig. 22). The presence of DNA breaks causes cells to accumulate in
G2/M phase (154, 155). By examining the cell cycle stage of the cell populations
during induction of MMS and washing out the DNA damaging agent, it was clear
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Figure 22: Old cells have impaired DSB repair. Analysis of intact yeast
chromosomes by PFGE from same numbers of young and old WT yeast cells for
each time point during repair a time-course as indicated in the figure. Samples
were collected before damage induction (Unt), addition of MMS to a final
concentration of 0.07% for 30 mins (MMS), and post-MMS removal and recovery
up to 6 hours (3 and 6, respectively). Samples in the first two lanes (Unt, MMS in
Young) are not purified through columns as required for collection of samples
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using MEP, as controls for the method. The panel shows staining pattern of
chromosomes by SYBR safe.
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that the young cells accumulate in G2/M phase consistent with activation of the
DNA damage checkpoint, following DNA damage and subsequently reenter the
cell cycle following DNA repair (Fig. 23). By contrast, the old cells were already
predominantly in G2/M phase even prior to inducing damage, indicating that they
may already be experiencing an activated cell cycle checkpoint due to DNA
damage (Fig. 23). This is consistent with old cells having more DNA damage
perhaps due to the inability of old cells to repair DSBs. Taken together, these
data clearly show that DSB repair is defective in old yeast cells.

4.2.4. Levels of several DNA repair proteins are reduced in old cells
Most DSB repair in yeast is performed by the homologous recombination
(HR) pathway (118). Therefore, I asked whether there are reduced levels of key
HR proteins in old cells. Indeed, the levels of several key proteins involved in
different stages of HR were severely reduced during aging when I compared the
protein levels in young and old cells (Fig. 24), including the resection proteins
Mre11 and Sae2, single strand DNA binding proteins RPA (Rfa1 and Rfa2), the
stand exchange protein Rad51, the DNA damage response kinase Rad53 and
Rad54, the protein involved in a late postsynaptic step of HR to complete the
repair process (117, 119, 156). The only HR protein that did not appear to have
significantly reduced levels during yeast aging was Rad52, Because the protein
levels of most key HR proteins were significantly reduced in old cells, it is likely
that this is the reason why DSB repair efficiency is compromised in aged yeast
cells.
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Figure 24. Reduced expression level is observed for key DNA repair
proteins in old cells. Western blot analysis to measure levels of key DNA repair
proteins in young and old cells. Samples are loaded according to equal cell
numbers. Left panel indicates proteins tested using available antibodies, while
panel in right shows HA-tagged proteins with untagged strain as additional
control. Histone H3 protein level has been shown in each case as a control,
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4.2.5. Over-expression of key DNA repair proteins (Rad51 and Mre11)
partially reverses the accumulation of DNA damage with age
To investigate whether the reduced levels of HR proteins in old cells is
responsible for the profound defect in DSB repair in old cells (Fig. 24), I
overexpressed an extra copy of several of the key HR proteins and asked if it
could restore DSB repair. We have shown previously that aged cells show
increased accumulation of γH2A foci, which is indicative of increased break
accumulation during aging (40). When I overexpressed Rad51, I found a
significant reduction of γH2A foci formation in old cells (Fig. 25A). Similarly,
overexpression of Mre11 also led to a significant reduction of γH2A foci formation
in old cells (Fig. 25B). It has been shown previously that an extra copy of the
RAD51 gene extends replicative lifespan in yeast (136). Taken together these
data indicate that the reduced DSB repair that occurs in old cells is possibly a
cause of aging, because partially fixing the DSB repair defect in old cells extends
replicative lifespan.

4.3. Conclusions
There are several lines of evidence that illustrates the necessity for proper
genome maintenance to rightfully execute different cellular functions (115, 116).
Given the gradual decline in all molecular and cellular functions during aging,
loss of genomic integrity has long been implicated as a causative factor for aging
(9). Significant increase in the accumulation of DNA breaks has already been
observed in replicatively aged yeast cells by our laboratory (40). In this chapter, I
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sought to characterize the potential mechanism behind the reason for this
increased genomic instability observed during aging.
My findings suggest that an aging genome accumulates random damage
as a function of time (Fig. 18, 19). I also found a direct correlation between rDNA
instability / ERC levels and accumulation of global chromosomal damage during
aging (Fig. 20). Specifically, global DSB damage accumulation was less in a
mutant (fob1∆) where the rDNA is less recombinogenic and has less ERCs
(110). It is believed for a long time that accumulation of DNA mutations over a
period of time impacts organismal aging (69, 70). However, a recent study
indicated that mere accumulation of somatic DNA mutations, at least in budding
yeast, does not have a causal role in aging by measuring de novo mutations in
daughters from mothers of different ages (71). Therefore, it needed to be
conclusively determined whether a declining DNA repair response was
responsible for the increased accumulation of damage as a function of age.
Here, using the replicatively aged yeast cells, I found an impaired DNA repair
response in aging cells that cannot resolve increasing accumulation of DNA
lesions efficiently (Fig. 22). Although I could not rule out the possibility that this
decline in DNA repair response is due to failure of specific DNA repair proteins to
be recruited at the DSB sites during aging, I uncovered that the levels of most of
the DNA repair proteins are lower in aged cells (Fig. 24). This indicates that while
the demand for the repair proteins is higher in aged cells due to an increased
burden of damage accumulation, the supply of repair proteins is lower, limiting
the ability of the aging cell to maintain its genomic integrity. I confirmed this by
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over-expressing specific proteins involved in the DNA repair response. Following
over-expression of specific repair proteins, I found that similar age-matched cells
to WT cells show lower abundance of DNA damage as indicated by decrease in
γH2A foci formation (Fig. 25), indicating an improved DNA repair response
following over-expression of these proteins. Over-expression of one of these
proteins, Rad51, has already been shown to extend budding yeast replicative
lifespan (136). Although the reason for this was unknown, this result together
with ours indicates that enhancement of the DSB repair response leads to
lifespan extension. Furthermore, I found evidence that maintaining rDNA stability
protects global genomic integrity during aging, as a strain with higher rDNA
stability and longer lifespan showed better chromosomal integrity in comparison
to WT age-matched yeast cells. Taken together, I conclude from this part of my
study that the combination of rDNA instability and lower levels of DNA repair
proteins possibly due to translation defects are accountable for the functional
decline of DNA repair in aged cells contributing to the loss of genomic integrity.
Maintaining or enhancing the repair response may possibly serve as a potential
way for the extension of replicative lifespan in budding yeast.
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CHAPTER 5: DISCUSSION &
FUTURE DIRECTIONS

105

DISCUSSION
The inherent complexity of aging biology is an ongoing area of interest, as
there are continued efforts to find out therapeutic ways to delay the onset of
aging or age-associated diseases. Understanding the molecular details during
the aging process is thus imperative to achieve that goal. During an organisms’
lifetime, aging cells experience diverse changes and the aging phenotypes are
the manifestation of the cumulative effect of all these alterations. Even after all
these efforts by multiple groups to understand aging biology, there are still large
gaps in our knowledge of what changes happen during aging. In this thesis work,
I have presented an unparalleled analysis of the changes an aging cell
experiences from a genomic integrity point of view. The goal of this work was to
attain a comprehensive understanding of the loss of function experienced by an
aging genome. To my advantage, I used the single-celled eukaryote budding
yeast RLS, which provides a simplified model of the organismal aging process.
Given the high similarity of signaling pathways among eukaryotic organisms, the
knowledge I gained from these analyses may apply to the aging process of
multicellular eukaryotes as well.
Here, in the work presented in chapters 3 and 4, I have uncovered a
global loss of cohesion occurring in replicatively aged cells and this is the likely
cause of increased rDNA instability and ERC accumulation in old cells, which we
find, in turn, leads to global genomic instability in replicatively old cells.
Furthermore, I have discovered a profound defect in DSB repair in replicatively
old yeast due to limiting levels of key components of the homologous
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recombination machinery. This DSB repair defect in old cells limits the replicative
lifespan, because restoration of DSB repair by overexpressing HR proteins
ameliorates age-associated changes, extending lifespan.
The vast majority of yeast aging studies to date have focused on
identifying different mutants or conditions that shorten or lengthen lifespan. This
was because budding yeast enables the accurate measurement of replicative
lifespan. Conversely, the experimental difficulty in collecting sufficient numbers of
old yeast is responsible for the very sparse knowledge of the phenotype,
physiology and molecular health of replicatively old yeast cells. The
transformative MEP genetic system has enabled the molecular study of
replicatively old yeast cells (100) really for the first time. I used the MEP in this
study to uncover novel events occurring in yeast that are at, or beyond, their
median replicative lifespan, providing extensive novel insight into genomic
integrity in these cells and its role in determining lifespan.

Loss of cohesion during replicative aging
The likely reason why I observed an increase in rDNA instability during
aging was the decreased cohesin occupancy at the rDNA locus of aged cells.
Loss of cohesion may serve as the reason behind unequal recombination in
between tandem repeats resulting in changes in repeat numbers. In addition to
the rDNA locus, cohesion defects observed during aging extended also to other
genomic sites including telomeric and centromeric regions in aged cells. This
defect is likely caused by the reduced levels of the limiting subunit of cohesin
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complex, Mcd1, due to reduced protein synthesis of Mcd1 during aging as found
from the work done in other studies in our lab (unpublished observations). Given
the reduced levels of cohesin in old cells, it is probable that there is a global loss
of cohesion in mitotically aged cells beyond the regions that we have examined.
The potential implications of this loss of cohesion for human disease and lifespan
are multifold. First, loss of cohesion at centromeres would lead to chromosome
loss and gain during mitotic aging. Indeed, cohesion loss has previously been
observed during meiotic aging mostly at centromeres, and to some degree at
chromosome arms. This loss of cohesion in meiosis has been demonstrated to
be the leading cause for mis-segregation of chromosomes associated with
advanced maternal age, giving rise to birth defects and developmental
abnormalities (157, 158). Loss of cohesion during mitotic aging would also
contribute towards increased genomic instability given that cohesin is recruited to
DSBs to promote accurate DSB repair (159, 160). Loss of cohesion would also
lead to unequal sister chromatid recombination as I observed during aging
between repeats and ERC accumulation.
The accumulation of ERCs has long been known to occur during yeast
aging and has even been proposed to be a causative reason for yeast aging
(32). However, the molecular reason for ERC accumulation during aging has
never been known. ERCs accumulate due to unequal sister chromatid
recombination between the rDNA repeats (107). The loss of cohesion during
aging that I have uncovered here is undoubtedly the cause for the accumulation
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of ERCs during aging, as cohesion is essential for equal sister chromatid
recombination between the rDNA repeats.
Formation of extrachromosomal circular DNA similar to ERCs has also
been reported during Drosophila aging (25). Importantly, extrachromosomal
circular DNAs also appear during both in vitro and in vivo aging of mammalian
cells (161, 162). It is possible that cohesion is also lost during aging of
metazoans including mammals, and is responsible for the circular DNA
accumulation seen in these systems. We know very little about the roles played
by these circular nucleic acids in complex model organisms during aging.
Interestingly, rDNA instability has been shown to occur during some adult solid
tumors as well (143), where cancer is a disease of aging. Given that previous
studies (149) have correlated the levels of non coding RNA from the rDNA with
lifespan in budding yeast, it is relevant that I have found that the vast majority of
the non-coding RNA transcription occurring during aging is coming from the
ERCs. This places ERCs center stage again for contributing to perturbing cellular
homeostasis, potentially by sequestering factors that are required for efficient
DSB repair. This brings us to the causal role that we have observed for rDNA
instability/ERCs in global chromosomal instability.

Instability of the rDNA and its influence on global chromosomal stability
during aging
My findings reveal inability of aging cells to maintain genomic integrity as
demonstrated by the accumulation of random damage along chromosome arms
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compromising chromosomal stability. This is most likely due to a declining DNA
repair efficiency in aging cells. But a potential influence of rDNA instability over
global genomic integrity cannot be ignored as well. It is probable that an unstable
rDNA locus and / or accumulated ERCs in the nucleolus that accumulates with
increased mitotic age, titrates key limiting factors, which would otherwise be
available to maintain genomic integrity, as suggested previously (29, 32). Future
studies should aim to determine whether key repair factors translocate to fragile
sites like rDNA in the genome during age progression.
Another study using the MEP, albeit analyzing much younger old cells that
had undergone approximately 9 divisions, compared to our analysis of cells that
have undergone 25 or more divisions, found reduced pausing of the replication
machinery at the RFB within the rDNA in older cells (163). The molecular reason
for this is currently unknown. Regardless, this result is consistent with the fact
that we find the level of DSBs close to the RFB to be similar in old and young
cells, while the efficiency of DSB repair is greatly reduced in old cells. As such, it
is possible that old cells have reduced generation of DSBs near the RFB
because of reduced replication fork pausing, but in old cells these DSBs are not
effectively repaired, leading to equivalent steady state levels of DSBs at the RFB
in young and old cells. This would be in agreement with the fact that the length of
chromosome XII in old cells adopts two primarily distinct lengths, as opposed to a
distribution of chromosome XII fragments that would result if there were multiple
unequal sister chromatid recombination events due to the loss of cohesion in old
cells. The fact that old cells only show two main lengths of chromosome XII
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indicates that either somehow all old cells undergo unequal sister chromatid
cohesion in order to yield similarly reduced and increased numbers of rDNA
repeats. Alternatively, there may be one event of unequal sister chromatid
recombination in middle age and subsequent cells maintain these numbers of
rDNA repeats, perhaps because old cells are unable to efficiently repair the DSB
at the RFB by recombination.

Reduced homologous recombination in yeast limits the replicative lifespan
My studies reveal a defect in DSB repair, presumably via homologous
recombination, in replicatively aged yeast cells that may function to limit
replicative lifespan. The importance of the role of DSB repair in determining
lifespan and normal cellular health is consistent with the fact that yeast deleted
for key HR proteins have a very short lifespan (153). I uncovered the molecular
reason for the HR repair defect in replicatively old yeast cells as reduced levels
of key HR proteins in old cells, possibly due to a defect in their protein synthesis
(Tyler lab, unpublished observation). In agreement with our observations in
yeast, a decline in HR repair efficiency has been reported during replicative
senescence of human fibroblast cells in vitro and also during meiotic aging in
germ cells of old Drosophila using reporter assays (68, 164). It is interesting to
note that replicative senescence of human fibroblasts was accompanied by
reduced levels of key HR proteins, including Rad51, Rad52, NBS1 and SIRT6
(68), demonstrating that reduced levels of key HR proteins is a common feature
of replicative aging of yeast and humans. In human fibroblasts, however, the HR
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repair defect during replicative senescence is likely due to reduced protein levels
of the histone deacetylase SIRT6, as SIRT6 overexpression reestablished DSB
repair (68).
Interestingly, maintaining the optimal levels of the HR protein Rad51
seems extremely important in maintaining genomic integrity. While deficiency of
Rad51 renders increased sensitivity for DNA damaging agents in both budding
and fission yeast (165, 166), targeted Rad51 disruption results into
accumulations of chromosomal aberrations leading to cell death in vertebrate
cells and cell lethality in mouse ES cells (167, 168). Rad51-overexpression also
has certain adverse effects on both yeast influencing DSB-induced HR and
mammalian cells promoting chromosomal instability (169-171). However, overexpression of a single copy of Rad51 in yeast seems to be better tolerated and is
in fact beneficial for longevity, as illustrated by moderate lifespan extension in
yeast (136). Our analyses further indicate that over-expression of a single copy
of Rad51 could partially fix the DSB repair defect in aged yeast cells, which may
serve as a potential reason behind the extension of replicative lifespan observed
following Rad51 over-expression. Importantly, a single extra copy overexpression of another protein implicated during DNA repair, Mre11, shows very
similar effect in aged cells in partially fixing the DSB repair defect. Although very
limited information is available about the effect of Mre11 over-expression,
previously deficiency for this protein has been shown to cause increased damage
sensitivity and a profound deficiency in DSB repair in budding yeast (172). Taken
together, these results indicate that decline in the level of key proteins during
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aging results into a compromised genomic integrity and modulating the level of
repair proteins in a balanced way to compensate the repair defect observed
during aging may serve as a potential way to extend lifespan.
As mentioned earlier, a declining HR response with replicative age seems
to be a more generalized phenomenon than previously assumed. Aging also
serves as the greatest carcinogen, and in certain instances aging and cancer
share common etiologies (76). An impaired HR response has long been
associated with increased genomic instability to initiate carcinogenesis as well
(173). While hypoxic microenvironment characteristic to cancer cells seems to
accelerate genomic instability by reducing Rad51 expression, therefore also
causing a reduction in HR efficiency (174), wide ranges of tumor tissues also
show elevated Rad51 levels (171, 175), which seems somewhat counterintuitive. In general genomic instability has a negative impact on cell growth.
Therefore, over-expression of Rad51 may be assumed as a plausible countermeasure taken by tumor cells with HR defects to selectively overcome that
defect, in order to re-gain genome stabilization as well as to experience a
survival advantage as proposed by one earlier model (173). Additionally, Rad51
over-expression is also associated with a number of consequences including
increased damage resistance. Over-expression of Rad51 possibly also
contributes for the resistance to radiation therapy or DNA damage therapeutics
for these tumors (171). Interestingly, in a similar fashion over-expression of
Mre11 has also previously been shown to promote radioresistance via an
enhanced DNA repair mechanism in breast cancer (176). How and where the
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mechanisms behind these two outcomes, a declining HR response during aging
and selective pressure of tumor cells to survive by overcoming that response
diverge remains subject to further investigation, but all these evidence further
emphasize that tightly controlled and balanced regulation of repair proteins is
crucial for proper functioning of the cells.
With mitotic age progression, the available cellular resources become
limiting, and problems start arising, including defective cohesion, defective DSB
repair and inaccurate repair of DSB lesions within the rDNA, as we have
uncovered here (Fig. 26). Eventually the limiting levels of repair factors and
cohesin in old cells causes the accumulation of genomic damage, chromosomal
rearrangements and potentially chromosome loss. We propose that eventually a
threshold of genomic damage is crossed that is sensed by the cell to cause cell
division to halt marking the end of the replicative lifecycle.

FUTURE DIRECTIONS
The major limitation in the field of aging research is that most of the time it
depends on correlational analysis. This is because of the difficulty in performing
functional analyses at the molecular level, the long length of the aging
experiments especially when performed in larger eukaryotes and the complexity
of aging biology with the potential influence of other environmental factors. There
is still a great deal to learn about this highly complex biological process.
Development of new vertebrate and invertebrate model systems suitable for
aging research such as African killifish and naked mole rats, and transformative
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Model for rDNA instability and reduced HR
causing global genomic instability to limit lifespan
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Figure 26. Working model for rDNA instability and reduced homologous
recombination (HR) causing global genomic instability to limit lifespan.
.
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genetic systems such as the MEP provide invaluable tools in this complex field of
research. Similarly, development of microfluidic systems also enables
researchers to perform broad genetic screens in a high throughput manner (98).
Our current progress in knowledge and extensive utilization of next-generation
sequencing techniques are further empowering us to analyze age-associated
changes at ever increasing resolution. These developments, together with
simultaneous gain-of-function or loss-of-function studies performed in different
organisms, will enable the field eventually to comprehend the causal effects of
certain pathways during aging, to move beyond correlation analyses.
The major body of research illustrated in this thesis work demonstrates
how genomic stability is perturbed during aging. However, we are only starting to
learn details about the molecular changes happening during aging, not relying
solely on the correlative analyses. But there is still a lot to learn about the
process and there are plenty of unanswered questions. I have observed altered
levels of key repair proteins in aged yeast cells, but my analyses were restricted
to only a few proteins. An unbiased approach may have been useful in
understanding the full detailed picture, such as quantitative mass spectrometry.
However, it needs to be kept in mind that aging cells undergo profound changes
in all macromolecular levels. Therefore, use of proper normalization controls and
cautious interpretation of results are extremely important to derive any logical
conclusion. It will be also interesting to find out whether there are certain
changes in cellular localization pattern of these repair proteins and if in aging
cells whether these proteins are sequestered to regions with high fragility. As
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mentioned earlier, a possible hypothesis suggests ERCs perturb cellular
homeostasis during aging, potentially by sequestering factors that are required
for efficient DSB repair. The use of a microfluidic platform coupled with highresolution microscopy will be helpful in addressing this question by tracking large
number of mother cells and following the events during aging. Specifically, it
would be of interest to use a marker of induced DNA damage response, to
visualize whether the DNA damage checkpoint is activated during the final
replicative cell cycle.
Since extra-chromosomal circular DNAs similar to ERCs have been found
in other organisms, and also in aged mammalian cells, another interesting aspect
of study will be to illustrate the roles of these circular nucleic acids in aging, and
also in other aspects, as we have very little knowledge about them. It will be also
of interest to learn if loss of cohesion serves as a causal factor to the generation
of these circular DNAs. As genomes of larger eukaryotes carry more repeat
sequences than budding yeast, it is highly likely to happen beyond yeast also. In
particular, it will be important to investigate the broader impact of loss of
cohesion during aging and to determine if this can serve as a cue for the cells to
end replicative lifespan. Analysis of cohesion using the GFP assay that I utilized
here, coupled with microfluidic analyses of the RLS would enable it to be
determined whether loss of cohesion was consistently apparent in the final cell
division. To determine whether the loss of centromeric cohesion leads to
aneuploidy during aging, chromosome loss assays should be performed during
the yeast RLS to determine if there is a threshold of maternal age above which
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chromosome loss and gain (aneuploidy) occurs, much like the threshold of age
for loss of heterozygosity (LOH) observed by Dan Gottschling’s laboratory
previously. To further analyze whether loss of cohesion is the cause of aging,
attempts should be made to overexpress cohesins, to see if they extend lifespan.
I attempted to do this with Mcd1, but the cells did not tolerate the overexpression
of Mcd1. Perhaps lower level expression could be attempted, to see if it will
extend the yeast RLS. I also used a strain where cohesin was artificially driven to
the rDNA via LacO arrays. Unfortunately, this shortened lifespan, presumably
due to persistent chromosome cohesion throughout the cell cycle (data not
shown). To determine the relevance of these studies beyond yeast, it will be of
interest to determine whether there is a loss of cohesion during mitotic aging in
other organisms, such as replicative senescence of human fibroblasts in culture,
or hematopoietic stem cells.
In addition, as we have observed over-expression of certain DNA repair
proteins could partially ameliorate certain aging phenotype, another interesting
area of study will be to address what specific changes are associated with the
compromised genome in aged cells and how over-expression of particular repair
proteins helps to overcome those defects to possibly extend lifespan. It will also
be interesting to know if it is a generalized response or only certain proteins
involved in the DNA repair pathway may serve as the aging factors. In this
context, it will be important to remember that many of the DNA repair factors are
involved in interconnected pathways. Therefore, caution should be taken when
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interpreting the results, to separate the effects of one pathway from the other and
in certain contexts it may be very difficult to address.
As genome instability serves as a general hallmark of aging and there is
evidence suggesting its conserved nature across different organisms, it will be
also interesting to test whether the molecular reasons for genome instability
uncovered in my analyses, such as cohesion loss, rDNA instability, and an
impaired repair response are responsible for aging pathways in other eukaryotes
as well. Besides the questions above, from a different approach, it will be
interesting to find out whether specific lifespan-extending regimens influence this
particular hallmark of aging to cause an extension of lifespan. For example, does
calorie restriction or rapamycin treatment promote genomic stability? Calorie
restriction is known to reduce ERC accumulation, and therefore it would be of
interest to look at the integrity of chromosomes during aging upon calorie
restriction, to provide further support for our hypotheses. However, any lifespanextending regimen will likely have an impact on multiple pathways, making it
difficult again to separate specific effects of individual pathways.
While some of the molecular changes observed during aging are
categorized as causal factors of aging, there are other changes that simply
accompany the aging process. While attempting to characterize the causes or
consequences of aging, extreme cautions need to be taken, because most of the
relevant pathways are interconnected with each other. It is thus necessary to
establish the hierarchical relationship among the relevant pathways to
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understand the causal network of aging in order to derive effective therapies to
counteract the aging process and to impede age-induced complications.
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APPENDIX 1: The commercial antibodies against histone H3 lysine 56
acetylation (H3K56Ac) are non-specific in vitro and in mammalian cells
This section is based upon our published work: Pal, S., Graves, H.,
Ohsawa, R., Huang, T.H., Wang, P., Harmacek, L., and Tyler, J. (2016). The
Commercial Antibodies Widely Used to Measure H3 K56 Acetylation Are NonSpecific in Human and Drosophila Cells. PLoS One 11, e0155409.
Copyright permission is not required as the copyright policy for PLos One
journal states “PLOS applies the Creative Commons Attribution (CC BY)
license to articles and other works we publish. If you submit your paper for
publication by PLOS, you agree to have the CC BY license applied to your work.
Under this Open Access license, you as the author agree that anyone can reuse
your article in whole or part for any purpose, for free, even for commercial
purposes. Anyone may copy, distribute, or reuse the content as long as the
author and original source are properly cited. This facilitates freedom in re-use
and also ensures that PLOS content can be mined without barriers for the needs
of research.”

INTRODUCTION:
Chromatin structure is the template for all different nuclear processes in all
eukaryotes. The basic repeating unit of chromatin is called the nucleosome. It
consists of approximately 147 base pairs of DNA wrapping two molecules of
each of the histone proteins, H2A, H2B, H3, and H4 around 1.75 times (177).
Nucleosomes are responsible for efficient packaging and protecting our entire
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genome. Earlier studies carried out in budding yeast showed that the histone
needs to be disassembled from chromatin structure for different processes such
as transcription, DNA repair, and replication to occur (178, 179). Chromatin
disassembly allows different other machineries mediating these genomic
processes to gain proper access to the DNA to perform their function efficiently.
The process of removal of histones from the DNA during these genomic events
is, in part, understood from the work done in budding yeast. But this process
requires the involvement of specific proteins called histone chaperones that bind
to the histones in a stoichiometric manner to remove them from the DNA (180).
Histone removal from the DNA is further facilitated by different post-translational
modifications (PTMs) of histone proteins that potentially weaken histone-DNA
interactions. One of such PTMs is acetylation of histone H3 lysine 56 (H3 K56Ac)
(181-183). Although the process of histone removal has been described in
budding yeast, it is yet to be determined whether similar mechanisms exist during
these genomic processes in metazoans as well.
The functional study of histone PTMs is rather simplified in budding yeast,
as there are only two copies for each histone genes and it is relatively easy to
study the functional effect of any histone PTM by mutating the histone encoding
genes. In sharp contrast, in metazoan cells, there are hundreds of genes
encoding each of the canonical histones (184). Therefore, our current knowledge
about histone PTMs in metazoan cells is mostly restricted to the correlation
analysis those examine the genome-wide distribution of histone PTMs (185).
However, these genome-wide analyses do not provide any functional studies of
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the histone PTMs, and more importantly, such correlative analyses are largely
dependent on the specificity of the antibodies used against a particular histone
PTM.
Histone H3 K56Ac has been initially identified by mass spectrometry
analysis in mammalian cells (186, 187). Acetylation at this site of histone H3 is
catalyzed by the histone acetyl transferases (HATs) CBP and p300 in
coordination with the histone chaperone Asf1 in humans. Chromatin
immunoprecipitation (ChIP) analyses demonstrating the localization pattern of H3
K56Ac in stem cells showed this modification to be associated with the regulatory
regions of different pluripotency genes (186), indicating a potential role of this
PTM in transcriptional regulation. Since then, large number of studies implicated
this PTM in transcriptional regulation in metazoan cells, mostly using commercial
antibodies against H3 K56Ac, and showing H3 K56Ac to be localized at active
promoters or enhancers in mammalian cells (186, 188-197). Of note, all newly
synthesized histone H3 proteins in budding yeast are acetylated on H3 K56
residue. In contrast, in human cells the abundance of this PTM is exceptionally
low. Mass spectrometry analysis suggests that only 0.03% of all histones carry
this particular PTM (198). Because of this difference, it is not possible to directly
apply the knowledge we gained from studies performed in budding yeast on
humans, as it may be inaccurate considering the physiological difference. All
these abovementioned studies imply possible roles H3 K56Ac play in
transcriptional regulation in metazoan systems mostly based on the of its
localization and/or distribution patterns. However, it is yet to be tested at the
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functional level. Earlier, mutational analysis in budding yeast showed that H3
K56Ac promotes transcriptional activation in budding yeast by promoting
chromatin disassembly by allowing histone proteins to be dissociated from
promoter regions more readily (199). Based on all these evidence, we were
interested to examine whether H3 K56Ac plays a similar role during transcription
in mammalian cells. As there are certain concerns raised about the specificity of
commercially available antibodies against H3 K56Ac (198), I rigorously tested the
specificity of the available commercial antibodies against H3 K56Ac. During our
analyses, I found that all of the commercially available H3 K56Ac antibodies
showed non-specificity when tested in vitro, and also in mammalian cells,
recognizing other acetylated lysine residues than lysine 56 on histone H3.
Therefore, our study provides the proof that the studies being performed in
mammalian cells using H3 K56Ac antibodies available commercially should be
interpreted with caution.

MATERIALS AND METHODS

Dot blot
Lyophilized peptides were rehydrated in 1X PBS at a 300 µM concentration and
then diluted 10 fold, prior to spotting 10 µl onto an activated PVDF membrane.
The membrane was air-dried and then stained with amido black to verify the
presence of the peptides. The membranes were washed in TBST and then
blocked in 3% non-fat milk in TBST. The blots were incubated in primary
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antibodies overnight at 4°C. The blots were washed and probed with specific
HRP conjugated secondary antibodies at room temperature for 1 hr.

Western blot
Acid extracted histones were separated by SDS-PAGE, probed with the indicated
antibodies in each figure. Where necessary, the secondary antibody IR dye
680RD Goat anti-Rabbit IgG (H + L) multiplexed with the IRDye® 800CW Goat
anti-Mouse IgG (H + L) was used for the 2-color detection method by the
Odyssey LI-COR imaging system. The H3 K56Ac antibodies used in this and
other experiments are: Epitomics monoclonal Ab (2134–1), Epigentek polyclonal
Ab (A-4026-050), Cell Signaling polyclonal Ab (4243S), Upstate polyclonal Ab
(07–677), Active Motif polyclonal Ab (39281), Active Motif monoclonal Ab
(61061). The other antibodies used are: N-terminal histone H3 mAb (Active Motif
39763), C-terminal histone H3 pAb (Abcam ab1791), IRDye 680 Goat anti-rabbit
IgG (LICOR 926–32221) and IRDye 800CW Goat anti-mouse IgG (LICOR 926–
32210).

Immunohistochemistry (IHC)
Slides containing paraffin embedded breast cancer tissue samples fixed in 10%
neutral buffered formalin were obtained from the MD Anderson Pathology core
and IHC method was optimized in assistance with the Pathology core. In short,
the sections of the tissues were deparaffinized with xylene and rehydrated in a
graded series of ethanol (two 100% ethanol wash, followed by 95% ethanol, 70%
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ethanol, 50% ethanol, 30% ethanol, followed by water). Antigen retrieval was
performed using heat-induced method following standard procedure. After
blocking non-specific binding, the sections were incubated with primary antibody
at indicated dilution (overnight, 4°C, humidified chamber) followed by incubation
with HRP-conjugated secondary antibody (1 hr, room temperature). For signal
detection, DAB substrate kit (Vector Laboratories) was used followed by
counterstaining with Mayer’s Hematoxylin (Sigma).

RESULTS AND DISCUSSION:
To ensure the specificity of the H3 K56Ac antibodies commercially
available, I used multiple approaches and tested the specificity of this PTM
rigorously both in vitro and in mammalian cells within the context of other cellular
proteins, which is more similar to physiological setting. I first performed a dot blot
analysis using purified peptides carrying specifically histone H3 K56Ac
modification, but I simultaneously also used other purified acetylated peptides on
other sites of histone H3, to ensure the specific binding of the antibody being
tested. On the dot blot, several of the commercial antibodies (Epitomics,
Epigentek, and Upstate) failed to recognize H3 K56Ac specifically and
recognized one or more other acetylated lysine residues from N-terminus of H3
in addition to recognizing the peptide carrying H3 K56Ac (Fig. 27). From the dot
blot analysis, it seemed that the more specific antibodies for H3 K56Ac were the
antibodies from Cell Signaling and Active Motif (two antibodies form Active Motif,
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Figure 26

Figure 27. The commercial antibodies against histone H3 lysine 56
acetylation (H3K56Ac) are non-specific in vitro. Dot blot analysis of the
indicated commercial H3 K56Ac antibodies, tested against the peptides indicated
above. 10 µl of each peptide at 300 µM concentration was spotted on the top
row, followed by 10 fold serial dilutions below. A short and longer exposure are
shown.
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one monoclonal, and one polyclonal). Therefore, we continued using these
antibodies for our next level of specificity test in mammalian cells.
Next, I analyzed the specificity of the antibodies in more physiologically
relevant condition that is in a crude protein extract. In a crude protein extract, all
the acetylated lysine residues would exist in physiologically relevant ratios as
similar to the level normally found inside the cell. To test the specificity of the H3
K56Ac antibodies mentioned above, I used mammalian H1299 and 293T cell
lines carrying stably integrated FLAG tagged H3.1 (200), carrying either a wild
type lysine (K) or lysine 56 (K56) mutated to arginine (R) to prevent acetylation at
this specific site. As the FLAG-tagged H3 expression level is only about 5% of
the level of endogenous histones, for this analysis I used acid extracted histones
to isolate enough amount of protein and to enrich for histone proteins to achieve
the level of detection for the FLAG-tagged H3 by western blot. Here in this
analysis, I included wild type 293T cells not expressing any tagged histones also
as a control, to ensure that the H3 K56Ac antibody was recognizing the right
band, and not just a background band. Both the histone H3 antibody and the H3
K56Ac antibodies being tested could recognize full length FLAG-tagged H3 (Fig.
28). Interestingly, I observed that all of the commercial H3 K56Ac antibodies
being tested here (Active Motif polyclonal, Active Motif monoclonal, Cell
Signaling, and Epitomics) could recognize the mutated residue (H3 K56R-FLAG
tagged protein) almost to the same efficiency as the wild type H3-FLAG (Fig. 28).
As K56R mutant is deficient in its ability to be acetylated on this residue, this
result indicates that all of these H3 K56Ac antibodies could recognize either
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Figure 27

Figure 28. The commercial antibodies against histone H3 lysine 56
acetylation (H3K56Ac) are non-specific when tested in mammalian cells.
Western blot analysis of acid extracted histones from 293 cells that were wild
type (WT) or stably expressed H3.1c-FLAG or H3.1c K56R-FLAG, or from H1299
cells that stably expressed H3.1c-FLAG or H3.1c K56R-FLAG. * indicates a
proteolytic degradation product of H3 generated by cleavage of the N-terminus
that occurs upon generating the total protein extracts. ** indicates a smaller H3
degradation product seen in the wild type sample only, due to possible over
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handling of the extract. Data is shown for the Active Motif, the Epitomics and the
Cell signalling H3 K56Ac antibodies. 75 micrograms of total protein extract was
loaded for each lane, and western blotted with the indicated antibodies, followed
by detection with infrared antibodies on a Licor Odyssey machine.
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histone H3 or other acetylated residues on histone H3 in the absence of H3
K56Ac. In order to eliminate the possibility that this non-specificity shown by
these antibodies was not due to excess antibody concentration being used, I
tried different dilutions of these antibodies to find an effective dilution at which
these antibodies would show specificity for H3 K56Ac residue. But for all the
dilutions I tested, all of these antibodies recognized both wild type H3-FLAG and
H3 K56R-FLAG almost to an equal level.
Because the Active Motif monoclonal antibody was the most recently
developed commercial antibody and it was supposed to a specific antibody for
the application of ChIP, for which the success of the application depends on the
ability of the antibody to recognize the native epitopes, I wanted to test the
specificity of this antibody for recognizing native epitopes but for the application
of immunohistochemistry (IHC), which utilizes a similar mode of recognition
following similar fixation approach (Fig. 29A, B). Interestingly, I found this
antibody to recognize significant amounts of cytoplasmic proteins, even at high
dilutions (Fig. 29B), further confirming its non-specificity as occurrence of H3
K56Ac is presumably mostly restricted to the nucleus given that this event is
mediated by p300 and CBP (187). We also further confirmed the non-specific
nature of these antibodies in an in vivo model using flies (201).
Taken together, all these data indicate that at least in my analyses, I could
not achieve enough specificity for any of the commercially available H3 K56Ac
antibodies, via dot blot, western analyses, or in certain instances IHC application.
The non-specificity conferred by these available H3 K56Ac antibodies would
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Figure 28

A

B

Figure 29. A commercial antibody against histone H3 lysine 56 acetylation
(H3K56Ac) showing specificity in vitro is non-specific when tested in breast
cancer tissue. (A) Immunohistochemintry (IHC) analysis of the Active Motif
monoclonal antibody, on breast cancer tissue samples shows non-specific
cytoplasmic staining instead of distinct nuclear staining. Green arrows point to
cytoplasm and black arrows point to nuclei. Both slides are also stained with
haematoxylin and eosin (H&E) stain, which stains nuclei blue and eosinophilic
structures pink. (B) IHC analysis of breast cancer tissue as (A), using either no
primary antibody or other indicated dilutions of the antibody being tested here.
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possibly explain the reason for the confusion for identifying the responsible
histone deacetylase (HDAC) in mammalian cells, because SIRT1, SIRT2, SIRT6,
HDAC1, and HDAC2 each have been reported as the potential H3 K56Ac HDAC
(187, 202-210). Furthermore, the non-specificity of these antibodies could also
explain the contradictory findings of the occurrence of H3 K56Ac during different
cellular events such as during the cell cycle and DNA repair (187, 200, 202, 211218). Therefore, data obtained with commercially available H3 K56Ac antibodies
in metazoan cells, is likely due to its ability to recognize additional acetylated
lysine residues on histone H3, and should be interpreted with utmost caution.

	
  

133

Bibliography

1. Moskalev, A. A., A. M. Aliper, Z. Smit-McBride, A. Buzdin, and A.
Zhavoronkov. 2014. Genetics and epigenetics of aging and longevity. Cell
Cycle 13: 1063-1077.
2. Brunet, A., and S. L. Berger. 2014. Epigenetics of aging and aging-related
disease. The journals of gerontology. Series A, Biological sciences and
medical sciences 69 Suppl 1: S17-20.
3. Kennedy, B. K., S. L. Berger, A. Brunet, J. Campisi, A. M. Cuervo, E. S.
Epel, C. Franceschi, G. J. Lithgow, R. I. Morimoto, J. E. Pessin, T. A.
Rando, A. Richardson, E. E. Schadt, T. Wyss-Coray, and F. Sierra. 2014.
Geroscience: linking aging to chronic disease. Cell 159: 709-713.
4. Feser, J., and J. Tyler. 2011. Chromatin structure as a mediator of aging.
FEBS Lett 585: 2041-2048.
5. Sen, P., P. P. Shah, R. Nativio, and S. L. Berger. 2016. Epigenetic
Mechanisms of Longevity and Aging. Cell 166: 822-839.
6. Pal, S., and J. K. Tyler. 2016. Epigenetics and aging. Science advances 2:
e1600584.
7. Booth, L. N., and A. Brunet. 2016. The Aging Epigenome. Mol Cell 62:
728-744.
8. Guarente, L., and C. Kenyon. 2000. Genetic pathways that regulate
ageing in model organisms. Nature 408: 255-262.

134

9. Lopez-Otin, C., M. A. Blasco, L. Partridge, M. Serrano, and G. Kroemer.
2013. The hallmarks of aging. Cell 153: 1194-1217.
10. Goldberg, A. D., C. D. Allis, and E. Bernstein. 2007. Epigenetics: a
landscape takes shape. Cell 128: 635-638.
11. Munoz-Najar, U., and J. M. Sedivy. 2011. Epigenetic control of aging.
Antioxidants & redox signaling 14: 241-259.
12. O'Sullivan, R. J., and J. Karlseder. 2012. The great unravelling: chromatin
as a modulator of the aging process. Trends Biochem Sci 37: 466-476.
13. Zane, L., V. Sharma, and T. Misteli. 2014. Common features of chromatin
in aging and cancer: cause or coincidence? Trends in cell biology 24: 686694.
14. Fraga, M. F., E. Ballestar, M. F. Paz, S. Ropero, F. Setien, M. L. Ballestar,
D. Heine-Suner, J. C. Cigudosa, M. Urioste, J. Benitez, M. Boix-Chornet,
A. Sanchez-Aguilera, C. Ling, E. Carlsson, P. Poulsen, A. Vaag, Z.
Stephan, T. D. Spector, Y. Z. Wu, C. Plass, and M. Esteller. 2005.
Epigenetic differences arise during the lifetime of monozygotic twins. Proc
Natl Acad Sci U S A 102: 10604-10609.
15. Sargent, M. 2010. Why twins age differently.
16. Poulsen, P., M. Esteller, A. Vaag, and M. F. Fraga. 2007. The epigenetic
basis of twin discordance in age-related diseases. Pediatric research 61:
38R-42R.
17. Herskind, A. M., M. McGue, N. V. Holm, T. I. Sorensen, B. Harvald, and J.
W. Vaupel. 1996. The heritability of human longevity: a population-based

135

study of 2872 Danish twin pairs born 1870-1900. Human genetics 97: 319323.
18. Kucharski, R., J. Maleszka, S. Foret, and R. Maleszka. 2008. Nutritional
control of reproductive status in honeybees via DNA methylation. Science
319: 1827-1830.
19. Luger, K., A. W. Mader, R. K. Richmond, D. F. Sargent, and T. J.
Richmond. 1997. Crystal structure of the nucleosome core particle at 2.8
A resolution. Nature 389: 251-260.
20. Kornberg, R. D. 1974. Chromatin structure: a repeating unit of histones
and DNA. Science 184: 868-871.
21. Maison, C., and G. Almouzni. 2004. HP1 and the dynamics of
heterochromatin maintenance. Nat Rev Mol Cell Biol 5: 296-304.
22. Villeponteau, B. 1997. The heterochromatin loss model of aging. Exp
Gerontol 32: 383-394.
23. Tsurumi, A., and W. X. Li. 2012. Global heterochromatin loss: a unifying
theory of aging? Epigenetics 7: 680-688.
24. Smeal, T., J. Claus, B. Kennedy, F. Cole, and L. Guarente. 1996. Loss of
transcriptional silencing causes sterility in old mother cells of S. cerevisiae.
Cell 84: 633-642.
25. Larson, K., S. J. Yan, A. Tsurumi, J. Liu, J. Zhou, K. Gaur, D. Guo, T. H.
Eickbush, and W. X. Li. 2012. Heterochromatin formation promotes
longevity and represses ribosomal RNA synthesis. PLoS Genet 8:
e1002473.

136

26. Haithcock, E., Y. Dayani, E. Neufeld, A. J. Zahand, N. Feinstein, A.
Mattout, Y. Gruenbaum, and J. Liu. 2005. Age-related changes of nuclear
architecture in Caenorhabditis elegans. Proc Natl Acad Sci U S A 102:
16690-16695.
27. Haigis, M. C., and D. A. Sinclair. 2010. Mammalian sirtuins: biological
insights and disease relevance. Annual review of pathology 5: 253-295.
28. Guarente, L. 2011. Franklin H. Epstein Lecture: Sirtuins, aging, and
medicine. The New England journal of medicine 364: 2235-2244.
29. Oberdoerffer, P., S. Michan, M. McVay, R. Mostoslavsky, J. Vann, S. K.
Park, A. Hartlerode, J. Stegmuller, A. Hafner, P. Loerch, S. M. Wright, K.
D. Mills, A. Bonni, B. A. Yankner, R. Scully, T. A. Prolla, F. W. Alt, and D.
A. Sinclair. 2008. SIRT1 redistribution on chromatin promotes genomic
stability but alters gene expression during aging. Cell 135: 907-918.
30. Kennedy, B. K., M. Gotta, D. A. Sinclair, K. Mills, D. S. McNabb, M.
Murthy, S. M. Pak, T. Laroche, S. M. Gasser, and L. Guarente. 1997.
Redistribution of silencing proteins from telomeres to the nucleolus is
associated with extension of life span in S. cerevisiae. Cell 89: 381-391.
31. Oberdoerffer, P., and D. A. Sinclair. 2007. The role of nuclear architecture
in genomic instability and ageing. Nat Rev Mol Cell Biol 8: 692-702.
32. Sinclair, D. A., and L. Guarente. 1997. Extrachromosomal rDNA circles--a
cause of aging in yeast. Cell 91: 1033-1042.

137

33. Kobayashi, T. 2011. Regulation of ribosomal RNA gene copy number and
its role in modulating genome integrity and evolutionary adaptability in
yeast. Cell Mol Life Sci 68: 1395-1403.
34. Shumaker, D. K., T. Dechat, A. Kohlmaier, S. A. Adam, M. R. Bozovsky,
M. R. Erdos, M. Eriksson, A. E. Goldman, S. Khuon, F. S. Collins, T.
Jenuwein, and R. D. Goldman. 2006. Mutant nuclear lamin A leads to
progressive alterations of epigenetic control in premature aging. Proc Natl
Acad Sci U S A 103: 8703-8708.
35. Scaffidi, P., and T. Misteli. 2006. Lamin A-dependent nuclear defects in
human aging. Science 312: 1059-1063.
36. Goldman, R. D., D. K. Shumaker, M. R. Erdos, M. Eriksson, A. E.
Goldman, L. B. Gordon, Y. Gruenbaum, S. Khuon, M. Mendez, R. Varga,
and F. S. Collins. 2004. Accumulation of mutant lamin A causes
progressive changes in nuclear architecture in Hutchinson-Gilford progeria
syndrome. Proc Natl Acad Sci U S A 101: 8963-8968.
37. Zhang, W., J. Li, K. Suzuki, J. Qu, P. Wang, J. Zhou, X. Liu, R. Ren, X.
Xu, A. Ocampo, T. Yuan, J. Yang, Y. Li, L. Shi, D. Guan, H. Pan, S. Duan,
Z. Ding, M. Li, F. Yi, R. Bai, Y. Wang, C. Chen, F. Yang, X. Li, Z. Wang, E.
Aizawa, A. Goebl, R. D. Soligalla, P. Reddy, C. R. Esteban, F. Tang, G. H.
Liu, and J. C. Belmonte. 2015. Aging stem cells. A Werner syndrome stem
cell model unveils heterochromatin alterations as a driver of human aging.
Science 348: 1160-1163.

138

38. Feser, J., D. Truong, C. Das, J. J. Carson, J. Kieft, T. Harkness, and J. K.
Tyler. 2010. Elevated histone expression promotes life span extension.
Mol Cell 39: 724-735.
39. Dang, W., K. K. Steffen, R. Perry, J. A. Dorsey, F. B. Johnson, A.
Shilatifard, M. Kaeberlein, B. K. Kennedy, and S. L. Berger. 2009. Histone
H4 lysine 16 acetylation regulates cellular lifespan. Nature 459: 802-807.
40. Hu, Z., K. Chen, Z. Xia, M. Chavez, S. Pal, J. H. Seol, C. C. Chen, W. Li,
and J. K. Tyler. 2014. Nucleosome loss leads to global transcriptional upregulation and genomic instability during yeast aging. Genes Dev 28: 396408.
41. Chen, K., Z. Hu, Z. Xia, D. Zhao, W. Li, and J. K. Tyler. 2015. The
Overlooked Fact: Fundamental Need for Spike-In Control for Virtually All
Genome-Wide Analyses. Mol Cell Biol 36: 662-667.
42. Lesur, I., and J. L. Campbell. 2004. The transcriptome of prematurely
aging yeast cells is similar to that of telomerase-deficient cells. Mol Biol
Cell 15: 1297-1312.
43. Liu, L., T. H. Cheung, G. W. Charville, B. M. Hurgo, T. Leavitt, J. Shih, A.
Brunet, and T. A. Rando. 2013. Chromatin modifications as determinants
of muscle stem cell quiescence and chronological aging. Cell reports 4:
189-204.
44. McCormick, M. A., J. R. Delaney, M. Tsuchiya, S. Tsuchiyama, A.
Shemorry, S. Sim, A. C. Chou, U. Ahmed, D. Carr, C. J. Murakami, J.
Schleit, G. L. Sutphin, B. M. Wasko, C. F. Bennett, A. M. Wang, B. Olsen,

139

R. P. Beyer, T. K. Bammler, D. Prunkard, S. C. Johnson, J. K.
Pennypacker, E. An, A. Anies, A. S. Castanza, E. Choi, N. Dang, S.
Enerio, M. Fletcher, L. Fox, S. Goswami, S. A. Higgins, M. A. Holmberg,
D. Hu, J. Hui, M. Jelic, K. S. Jeong, E. Johnston, E. O. Kerr, J. Kim, D.
Kim, K. Kirkland, S. Klum, S. Kotireddy, E. Liao, M. Lim, M. S. Lin, W. C.
Lo, D. Lockshon, H. A. Miller, R. M. Moller, B. Muller, J. Oakes, D. N. Pak,
Z. J. Peng, K. M. Pham, T. G. Pollard, P. Pradeep, D. Pruett, D. Rai, B.
Robison, A. A. Rodriguez, B. Ros, M. Sage, M. K. Singh, E. D. Smith, K.
Snead, A. Solanky, B. L. Spector, K. K. Steffen, B. N. Tchao, M. K. Ting,
H. Vander Wende, D. Wang, K. L. Welton, E. A. Westman, R. B. Brem, X.
G. Liu, Y. Suh, Z. Zhou, M. Kaeberlein, and B. K. Kennedy. 2015. A
Comprehensive Analysis of Replicative Lifespan in 4,698 Single-Gene
Deletion Strains Uncovers Conserved Mechanisms of Aging. Cell
metabolism 22: 895-906.
45. Lee, C., and V. Longo. 2016. Dietary restriction with and without caloric
restriction for healthy aging. F1000Research 5.
46. McColl, G., D. W. Killilea, A. E. Hubbard, M. C. Vantipalli, S. Melov, and
G. J. Lithgow. 2008. Pharmacogenetic analysis of lithium-induced delayed
aging in Caenorhabditis elegans. J Biol Chem 283: 350-357.
47. Ni, Z., A. Ebata, E. Alipanahiramandi, and S. S. Lee. 2012. Two SET
domain containing genes link epigenetic changes and aging in
Caenorhabditis elegans. Aging Cell 11: 315-325.

140

48. O'Sullivan, R. J., S. Kubicek, S. L. Schreiber, and J. Karlseder. 2010.
Reduced histone biosynthesis and chromatin changes arising from a
damage signal at telomeres. Nat Struct Mol Biol 17: 1218-1225.
49. Ivanov, A., J. Pawlikowski, I. Manoharan, J. van Tuyn, D. M. Nelson, T. S.
Rai, P. P. Shah, G. Hewitt, V. I. Korolchuk, J. F. Passos, H. Wu, S. L.
Berger, and P. D. Adams. 2013. Lysosome-mediated processing of
chromatin in senescence. J Cell Biol 202: 129-143.
50. Vijg, J., and Y. Suh. 2013. Genome instability and aging. Annual review of
physiology 75: 645-668.
51. Maslov, A. Y., and J. Vijg. 2009. Genome instability, cancer and aging.
Biochim Biophys Acta 1790: 963-969.
52. Sedelnikova, O. A., I. Horikawa, D. B. Zimonjic, N. C. Popescu, W. M.
Bonner, and J. C. Barrett. 2004. Senescing human cells and ageing mice
accumulate DNA lesions with unrepairable double-strand breaks. Nat Cell
Biol 6: 168-170.
53. Sedelnikova, O. A., I. Horikawa, C. Redon, A. Nakamura, D. B. Zimonjic,
N. C. Popescu, and W. M. Bonner. 2008. Delayed kinetics of DNA doublestrand break processing in normal and pathological aging. Aging Cell 7:
89-100.
54. Mah, L. J., A. El-Osta, and T. C. Karagiannis. 2010. gammaH2AX: a
sensitive molecular marker of DNA damage and repair. Leukemia 24: 679686.

141

55. Liu, B., R. Yip, and Z. Zhou. 2012. Chromatin remodeling, DNA damage
repair and aging. Current genomics 13: 533-547.
56. Forsberg, L. A., C. Rasi, H. R. Razzaghian, G. Pakalapati, L. Waite, K. S.
Thilbeault, A. Ronowicz, N. E. Wineinger, H. K. Tiwari, D. Boomsma, M. P.
Westerman, J. R. Harris, R. Lyle, M. Essand, F. Eriksson, T. L. Assimes,
C. Iribarren, E. Strachan, T. P. O'Hanlon, L. G. Rider, F. W. Miller, V.
Giedraitis, L. Lannfelt, M. Ingelsson, A. Piotrowski, N. L. Pedersen, D.
Absher, and J. P. Dumanski. 2012. Age-related somatic structural
changes in the nuclear genome of human blood cells. American journal of
human genetics 90: 217-228.
57. Faggioli, F., T. Wang, J. Vijg, and C. Montagna. 2012. Chromosomespecific accumulation of aneuploidy in the aging mouse brain. Hum Mol
Genet 21: 5246-5253.
58. Wang, J., G. J. Geesman, S. L. Hostikka, M. Atallah, B. Blackwell, E. Lee,
P. J. Cook, B. Pasaniuc, G. Shariat, E. Halperin, M. Dobke, M. G.
Rosenfeld, I. K. Jordan, and V. V. Lunyak. 2011. Inhibition of activated
pericentromeric SINE/Alu repeat transcription in senescent human adult
stem cells reinstates self-renewal. Cell Cycle 10: 3016-3030.
59. Li, W., L. Prazak, N. Chatterjee, S. Gruninger, L. Krug, D. Theodorou, and
J. Dubnau. 2013. Activation of transposable elements during aging and
neuronal decline in Drosophila. Nature neuroscience 16: 529-531.
60. Dennis, S., U. Sheth, J. L. Feldman, K. A. English, and J. R. Priess. 2012.
C. elegans germ cells show temperature and age-dependent expression

142

of Cer1, a Gypsy/Ty3-related retrotransposon. PLoS pathogens 8:
e1002591.
61. Maxwell, P. H., W. C. Burhans, and M. J. Curcio. 2011. Retrotransposition
is associated with genome instability during chronological aging. Proc Natl
Acad Sci U S A 108: 20376-20381.
62. De Cecco, M., S. W. Criscione, E. J. Peckham, S. Hillenmeyer, E. A.
Hamm, J. Manivannan, A. L. Peterson, J. A. Kreiling, N. Neretti, and J. M.
Sedivy. 2013. Genomes of replicatively senescent cells undergo global
epigenetic changes leading to gene silencing and activation of
transposable elements. Aging Cell 12: 247-256.
63. De Cecco, M., S. W. Criscione, A. L. Peterson, N. Neretti, J. M. Sedivy,
and J. A. Kreiling. 2013. Transposable elements become active and
mobile in the genomes of aging mammalian somatic tissues. Aging
(Albany NY) 5: 867-883.
64. Wood, J. G., and S. L. Helfand. 2013. Chromatin structure and
transposable elements in organismal aging. Frontiers in genetics 4: 274.
65. Kanfi, Y., S. Naiman, G. Amir, V. Peshti, G. Zinman, L. Nahum, Z. BarJoseph, and H. Y. Cohen. 2012. The sirtuin SIRT6 regulates lifespan in
male mice. Nature 483: 218-221.
66. Mostoslavsky, R., K. F. Chua, D. B. Lombard, W. W. Pang, M. R. Fischer,
L. Gellon, P. Liu, G. Mostoslavsky, S. Franco, M. M. Murphy, K. D. Mills,
P. Patel, J. T. Hsu, A. L. Hong, E. Ford, H. L. Cheng, C. Kennedy, N.
Nunez, R. Bronson, D. Frendewey, W. Auerbach, D. Valenzuela, M.

143

Karow, M. O. Hottiger, S. Hursting, J. C. Barrett, L. Guarente, R. Mulligan,
B. Demple, G. D. Yancopoulos, and F. W. Alt. 2006. Genomic instability
and aging-like phenotype in the absence of mammalian SIRT6. Cell 124:
315-329.
67. Van Meter, M., M. Kashyap, S. Rezazadeh, A. J. Geneva, T. D. Morello,
A. Seluanov, and V. Gorbunova. 2014. SIRT6 represses LINE1
retrotransposons by ribosylating KAP1 but this repression fails with stress
and age. Nature communications 5: 5011.
68. Mao, Z., X. Tian, M. Van Meter, Z. Ke, V. Gorbunova, and A. Seluanov.
2012. Sirtuin 6 (SIRT6) rescues the decline of homologous recombination
repair during replicative senescence. Proc Natl Acad Sci U S A 109:
11800-11805.
69. Vijg, J., and M. E. Dolle. 2002. Large genome rearrangements as a
primary cause of aging. Mech Ageing Dev 123: 907-915.
70. Garcia, A. M., R. B. Calder, M. E. Dolle, M. Lundell, P. Kapahi, and J. Vijg.
2010. Age- and temperature-dependent somatic mutation accumulation in
Drosophila melanogaster. PLoS Genet 6: e1000950.
71. Kaya, A., A. V. Lobanov, and V. N. Gladyshev. 2015. Evidence that
mutation accumulation does not cause aging in Saccharomyces
cerevisiae. Aging Cell 14: 366-371.
72. Lombard, D. B., K. F. Chua, R. Mostoslavsky, S. Franco, M. Gostissa, and
F. W. Alt. 2005. DNA repair, genome stability, and aging. Cell 120: 497512.

144

73. MacRae, S. L., M. M. Croken, R. B. Calder, A. Aliper, B. Milholland, R. R.
White, A. Zhavoronkov, V. N. Gladyshev, A. Seluanov, V. Gorbunova, Z.
D. Zhang, and J. Vijg. 2015. DNA repair in species with extreme lifespan
differences. Aging (Albany NY) 7: 1171-1184.
74. Campisi, J., J. K. Andersen, P. Kapahi, and S. Melov. 2011. Cellular
senescence: a link between cancer and age-related degenerative
disease? Seminars in cancer biology 21: 354-359.
75. Campisi, J. 2013. Aging, cellular senescence, and cancer. Annual review
of physiology 75: 685-705.
76. Finkel, T., M. Serrano, and M. A. Blasco. 2007. The common biology of
cancer and ageing. Nature 448: 767-774.
77. Hanahan, D., and R. A. Weinberg. 2011. Hallmarks of cancer: the next
generation. Cell 144: 646-674.
78. Wolters, S., and B. Schumacher. 2013. Genome maintenance and
transcription integrity in aging and disease. Frontiers in genetics 4: 19.
79. Hasty, P., J. Campisi, J. Hoeijmakers, H. van Steeg, and J. Vijg. 2003.
Aging and genome maintenance: lessons from the mouse? Science 299:
1355-1359.
80. Burtner, C. R., and B. K. Kennedy. 2010. Progeria syndromes and ageing:
what is the connection? Nat Rev Mol Cell Biol 11: 567-578.
81. Arancio, W., G. Pizzolanti, S. I. Genovese, M. Pitrone, and C. Giordano.
2014. Epigenetic involvement in Hutchinson-Gilford progeria syndrome: a
mini-review. Gerontology 60: 197-203.

145

82. Misteli, T., and P. Scaffidi. 2005. Genome instability in progeria: when
repair gets old. Nature medicine 11: 718-719.
83. Tissenbaum, H. A., and L. Guarente. 2002. Model organisms as a guide to
mammalian aging. Developmental cell 2: 9-19.
84. Harel, I., B. A. Benayoun, B. Machado, P. P. Singh, C. K. Hu, M. F. Pech,
D. R. Valenzano, E. Zhang, S. C. Sharp, S. E. Artandi, and A. Brunet.
2015. A platform for rapid exploration of aging and diseases in a naturally
short-lived vertebrate. Cell 160: 1013-1026.
85. Bitterman, K. J., O. Medvedik, and D. A. Sinclair. 2003. Longevity
regulation in Saccharomyces cerevisiae: linking metabolism, genome
stability, and heterochromatin. Microbiol Mol Biol Rev 67: 376-399, table of
contents.
86. Steinkraus, K. A., M. Kaeberlein, and B. K. Kennedy. 2008. Replicative
aging in yeast: the means to the end. Annu Rev Cell Dev Biol 24: 29-54.
87. Longo, V. D., G. S. Shadel, M. Kaeberlein, and B. Kennedy. 2012.
Replicative and chronological aging in Saccharomyces cerevisiae. Cell
metabolism 16: 18-31.
88. Fabrizio, P., and V. D. Longo. 2007. The chronological life span of
Saccharomyces cerevisiae. Methods Mol Biol 371: 89-95.
89. Mortimer, R. K., and J. R. Johnston. 1959. Life span of individual yeast
cells. Nature 183: 1751-1752.
90. Steffen, K. K., B. K. Kennedy, and M. Kaeberlein. 2009. Measuring
replicative life span in the budding yeast. J Vis Exp.

146

91. Sutphin, G. L., J. R. Delaney, and M. Kaeberlein. 2014. Replicative life
span analysis in budding yeast. Methods Mol Biol 1205: 341-357.
92. Lee, S. S., I. Avalos Vizcarra, D. H. Huberts, L. P. Lee, and M.
Heinemann. 2012. Whole lifespan microscopic observation of budding
yeast aging through a microfluidic dissection platform. Proc Natl Acad Sci
U S A 109: 4916-4920.
93. Egilmez, N. K., J. B. Chen, and S. M. Jazwinski. 1990. Preparation and
partial characterization of old yeast cells. Journal of gerontology 45: B917.
94. Kennedy, B. K., N. R. Austriaco, Jr., and L. Guarente. 1994. Daughter
cells of Saccharomyces cerevisiae from old mothers display a reduced life
span. J Cell Biol 127: 1985-1993.
95. Muller, I. 1971. Experiments on ageing in single cells of Saccharomyces
cerevisiae. Archiv fur Mikrobiologie 77: 20-25.
96. Pichova, A., D. Vondrakova, and M. Breitenbach. 1997. Mutants in the
Saccharomyces cerevisiae RAS2 gene influence life span, cytoskeleton,
and regulation of mitosis. Canadian journal of microbiology 43: 774-781.
97. Bacon, J. S., E. D. Davidson, D. Jones, and I. F. Taylor. 1966. The
location of chitin in the yeast cell wall. The Biochemical journal 101: 36C38C.
98. Jo, M. C., W. Liu, L. Gu, W. Dang, and L. Qin. 2015. High-throughput
analysis of yeast replicative aging using a microfluidic system. Proc Natl
Acad Sci U S A 112: 9364-9369.

147

99. Lin, S. S., J. K. Manchester, and J. I. Gordon. 2001. Enhanced
gluconeogenesis and increased energy storage as hallmarks of aging in
Saccharomyces cerevisiae. J Biol Chem 276: 36000-36007.
100.

Lindstrom, D. L., and D. E. Gottschling. 2009. The mother

enrichment program: a genetic system for facile replicative life span
analysis in Saccharomyces cerevisiae. Genetics 183: 413-422, 411SI413SI.
101.

Kobayashi, T. 2006. Strategies to maintain the stability of the

ribosomal RNA gene repeats--collaboration of recombination, cohesion,
and condensation. Genes Genet Syst 81: 155-161.
102.

Kobayashi, T. 2011. How does genome instability affect lifespan?:

roles of rDNA and telomeres. Genes Cells 16: 617-624.
103.

Kobayashi, T. 2008. A new role of the rDNA and nucleolus in the

nucleus--rDNA instability maintains genome integrity. Bioessays 30: 267272.
104.

Ganley, A. R., S. Ide, K. Saka, and T. Kobayashi. 2009. The effect

of replication initiation on gene amplification in the rDNA and its
relationship to aging. Mol Cell 35: 683-693.
105.

Unal, E., B. Kinde, and A. Amon. 2011. Gametogenesis eliminates

age-induced cellular damage and resets life span in yeast. Science 332:
1554-1557.

148

106.

Sinclair, D. A., K. Mills, and L. Guarente. 1997. Accelerated aging

and nucleolar fragmentation in yeast sgs1 mutants. Science 277: 13131316.
107.

Sinclair, D. A., K. Mills, and L. Guarente. 1998. Molecular

mechanisms of yeast aging. Trends Biochem Sci 23: 131-134.
108.

Kaeberlein, M., K. T. Kirkland, S. Fields, and B. K. Kennedy. 2005.

Genes determining yeast replicative life span in a long-lived genetic
background. Mech Ageing Dev 126: 491-504.
109.

Kaeberlein, M., M. McVey, and L. Guarente. 1999. The SIR2/3/4

complex and SIR2 alone promote longevity in Saccharomyces cerevisiae
by two different mechanisms. Genes Dev 13: 2570-2580.
110.

Defossez, P. A., R. Prusty, M. Kaeberlein, S. J. Lin, P. Ferrigno, P.

A. Silver, R. L. Keil, and L. Guarente. 1999. Elimination of replication block
protein Fob1 extends the life span of yeast mother cells. Mol Cell 3: 447455.
111.

Kaeberlein, M. 2010. Lessons on longevity from budding yeast.

Nature 464: 513-519.
112.

Ganley, A. R., and T. Kobayashi. 2014. Ribosomal DNA and

cellular senescence: new evidence supporting the connection between
rDNA and aging. FEMS yeast research 14: 49-59.
113.

Kobayashi, T., and A. R. Ganley. 2005. Recombination regulation

by transcription-induced cohesin dissociation in rDNA repeats. Science
309: 1581-1584.

149

114.

Mehta, A., and J. E. Haber. 2014. Sources of DNA double-strand

breaks and models of recombinational DNA repair. Cold Spring Harbor
perspectives in biology 6: a016428.
115.

Ciccia, A., and S. J. Elledge. 2010. The DNA damage response:

making it safe to play with knives. Mol Cell 40: 179-204.
116.

Polo, S. E., and S. P. Jackson. 2011. Dynamics of DNA damage

response proteins at DNA breaks: a focus on protein modifications. Genes
Dev 25: 409-433.
117.

Li, X., and W. D. Heyer. 2008. Homologous recombination in DNA

repair and DNA damage tolerance. Cell research 18: 99-113.
118.

Paques, F., and J. E. Haber. 1999. Multiple pathways of

recombination induced by double-strand breaks in Saccharomyces
cerevisiae. Microbiol Mol Biol Rev 63: 349-404.
119.

Jasin, M., and R. Rothstein. 2013. Repair of strand breaks by

homologous recombination. Cold Spring Harbor perspectives in biology 5:
a012740.
120.

Sung, P., and H. Klein. 2006. Mechanism of homologous

recombination: mediators and helicases take on regulatory functions. Nat
Rev Mol Cell Biol 7: 739-750.
121.

Burgess, R. C., T. Misteli, and P. Oberdoerffer. 2012. DNA

damage, chromatin, and transcription: the trinity of aging. Curr Opin Cell
Biol.

150

122.

Chen, J. H., C. N. Hales, and S. E. Ozanne. 2007. DNA damage,

cellular senescence and organismal ageing: causal or correlative? Nucleic
Acids Res 35: 7417-7428.
123.

Gorbunova, V., and A. Seluanov. 2016. DNA double strand break

repair, aging and the chromatin connection. Mutat Res 788: 2-6.
124.

White, R. R., and J. Vijg. 2016. Do DNA Double-Strand Breaks

Drive Aging? Mol Cell 63: 729-738.
125.

Meyer, J. N., W. A. Boyd, G. A. Azzam, A. C. Haugen, J. H.

Freedman, and B. Van Houten. 2007. Decline of nucleotide excision repair
capacity in aging Caenorhabditis elegans. Genome biology 8: R70.
126.

Rao, K. S. 2007. DNA repair in aging rat neurons. Neuroscience

145: 1330-1340.
127.

Goukassian, D., F. Gad, M. Yaar, M. S. Eller, U. S. Nehal, and B.

A. Gilchrest. 2000. Mechanisms and implications of the age-associated
decrease in DNA repair capacity. Faseb J 14: 1325-1334.
128.

Chen, J. H., C. N. Hales, and S. E. Ozanne. 2007. DNA damage,

cellular senescence and organismal ageing: causal or correlative? Nucleic
Acids Res 35: 7417-7428.
129.

Singh, N. P., D. B. Danner, R. R. Tice, L. Brant, and E. L.

Schneider. 1990. DNA damage and repair with age in individual human
lymphocytes. Mutat Res 237: 123-130.

151

130.

Mayer, P. J., C. S. Lange, M. O. Bradley, and W. W. Nichols. 1989.

Age-dependent decline in rejoining of X-ray-induced DNA double-strand
breaks in normal human lymphocytes. Mutat Res 219: 95-100.
131.

Garm, C., M. Moreno-Villanueva, A. Burkle, I. Petersen, V. A. Bohr,

K. Christensen, and T. Stevnsner. 2013. Age and gender effects on DNA
strand break repair in peripheral blood mononuclear cells. Aging Cell 12:
58-66.
132.

Longtine, M. S., A. McKenzie, 3rd, D. J. Demarini, N. G. Shah, A.

Wach, A. Brachat, P. Philippsen, and J. R. Pringle. 1998. Additional
modules for versatile and economical PCR-based gene deletion and
modification in Saccharomyces cerevisiae. Yeast 14: 953-961.
133.

Ide, S., T. Miyazaki, H. Maki, and T. Kobayashi. 2010. Abundance

of ribosomal RNA gene copies maintains genome integrity. Science 327:
693-696.
134.

Hoffman, C. S., and F. Winston. 1987. A ten-minute DNA

preparation from yeast efficiently releases autonomous plasmids for
transformation of Escherichia coli. Gene 57: 267-272.
135.

Gietz, D., A. St Jean, R. A. Woods, and R. H. Schiestl. 1992.

Improved method for high efficiency transformation of intact yeast cells.
Nucleic Acids Res 20: 1425.
136.

Dang, W., G. L. Sutphin, J. A. Dorsey, G. L. Otte, K. Cao, R. M.

Perry, J. J. Wanat, D. Saviolaki, C. J. Murakami, S. Tsuchiyama, B.
Robison, B. D. Gregory, M. Vermeulen, R. Shiekhattar, F. B. Johnson, B.

152

K. Kennedy, M. Kaeberlein, and S. L. Berger. 2014. Inactivation of Yeast
Isw2 Chromatin Remodeling Enzyme Mimics Longevity Effect of Calorie
Restriction via Induction of Genotoxic Stress Response. Cell metabolism.
137.

Weitao, T., M. Budd, L. L. Hoopes, and J. L. Campbell. 2003. Dna2

helicase/nuclease causes replicative fork stalling and double-strand
breaks in the ribosomal DNA of Saccharomyces cerevisiae. J Biol Chem
278: 22513-22522.
138.

Park, P. U., M. McVey, and L. Guarente. 2002. Separation of

mother and daughter cells. Methods in enzymology 351: 468-477.
139.

Tamburini, B. A., and J. K. Tyler. 2005. Localized histone

acetylation and deacetylation triggered by the homologous recombination
pathway of double-strand DNA repair. Mol Cell Biol 25: 4903-4913.
140.

Chen, C. C., J. J. Carson, J. Feser, B. Tamburini, S. Zabaronick, J.

Linger, and J. K. Tyler. 2008. Acetylated lysine 56 on histone H3 drives
chromatin assembly after repair and signals for the completion of repair.
Cell 134: 231-243.
141.

Szilard, R. K., P. E. Jacques, L. Laramee, B. Cheng, S. Galicia, A.

R. Bataille, M. Yeung, M. Mendez, M. Bergeron, F. Robert, and D.
Durocher. 2010. Systematic identification of fragile sites via genome-wide
location analysis of gamma-H2AX. Nat Struct Mol Biol 17: 299-305.
142.

Lindstrom, D. L., C. K. Leverich, K. A. Henderson, and D. E.

Gottschling. 2011. Replicative age induces mitotic recombination in the

153

ribosomal RNA gene cluster of Saccharomyces cerevisiae. PLoS Genet 7:
e1002015.
143.

Stults, D. M., M. W. Killen, E. P. Williamson, J. S. Hourigan, H. D.

Vargas, S. M. Arnold, J. A. Moscow, and A. J. Pierce. 2009. Human rRNA
gene clusters are recombinational hotspots in cancer. Cancer Res 69:
9096-9104.
144.

Huang, J., and D. Moazed. 2003. Association of the RENT complex

with nontranscribed and coding regions of rDNA and a regional
requirement for the replication fork block protein Fob1 in rDNA silencing.
Genes Dev 17: 2162-2176.
145.

Ganley, A. R., K. Hayashi, T. Horiuchi, and T. Kobayashi. 2005.

Identifying gene-independent noncoding functional elements in the yeast
ribosomal DNA by phylogenetic footprinting. Proc Natl Acad Sci U S A
102: 11787-11792.
146.

Cesarini, E., F. R. Mariotti, F. Cioci, and G. Camilloni. 2010. RNA

polymerase I transcription silences noncoding RNAs at the ribosomal DNA
locus in Saccharomyces cerevisiae. Eukaryot Cell 9: 325-335.
147.

Heidinger-Pauli, J. M., O. Mert, C. Davenport, V. Guacci, and D.

Koshland. 2010. Systematic reduction of cohesin differentially affects
chromosome segregation, condensation, and DNA repair. Curr Biol 20:
957-963.
148.

Laloraya, S., V. Guacci, and D. Koshland. 2000. Chromosomal

addresses of the cohesin component Mcd1p. J Cell Biol 151: 1047-1056.

154

149.

Saka, K., S. Ide, A. R. Ganley, and T. Kobayashi. 2013. Cellular

senescence in yeast is regulated by rDNA noncoding transcription. Curr
Biol 23: 1794-1798.
150.

Freitas, A. A., and J. P. de Magalhaes. 2011. A review and

appraisal of the DNA damage theory of ageing. Mutat Res 728: 12-22.
151.

Burhans, W. C., and M. Weinberger. 2012. DNA damage and DNA

replication stress in yeast models of aging. Sub-cellular biochemistry 57:
187-206.
152.

Kyng, K. J., A. May, T. Stevnsner, K. G. Becker, S. Kolvra, and V.

A. Bohr. 2005. Gene expression responses to DNA damage are altered in
human aging and in Werner Syndrome. Oncogene 24: 5026-5042.
153.

Park, P. U., P. A. Defossez, and L. Guarente. 1999. Effects of

mutations in DNA repair genes on formation of ribosomal DNA circles and
life span in Saccharomyces cerevisiae. Mol Cell Biol 19: 3848-3856.
154.

Weinert, T. A., and L. H. Hartwell. 1988. The RAD9 gene controls

the cell cycle response to DNA damage in Saccharomyces cerevisiae.
Science 241: 317-322.
155.

Stark, G. R., and W. R. Taylor. 2004. Analyzing the G2/M

checkpoint. Methods Mol Biol 280: 51-82.
156.

Renkawitz, J., C. A. Lademann, and S. Jentsch. 2014. Mechanisms

and principles of homology search during recombination. Nat Rev Mol Cell
Biol 15: 369-383.

155

157.

Lister, L. M., A. Kouznetsova, L. A. Hyslop, D. Kalleas, S. L. Pace,

J. C. Barel, A. Nathan, V. Floros, C. Adelfalk, Y. Watanabe, R.
Jessberger, T. B. Kirkwood, C. Hoog, and M. Herbert. 2010. Age-related
meiotic segregation errors in mammalian oocytes are preceded by
depletion of cohesin and Sgo2. Curr Biol 20: 1511-1521.
158.

Chiang, T., F. E. Duncan, K. Schindler, R. M. Schultz, and M. A.

Lampson. 2010. Evidence that weakened centromere cohesion is a
leading cause of age-related aneuploidy in oocytes. Curr Biol 20: 15221528.
159.

Brooker, A. S., and K. M. Berkowitz. 2014. The roles of cohesins in

mitosis, meiosis, and human health and disease. Methods Mol Biol 1170:
229-266.
160.

Peters, J. M., A. Tedeschi, and J. Schmitz. 2008. The cohesin

complex and its roles in chromosome biology. Genes Dev 22: 3089-3114.
161.

Kunisada, T., H. Yamagishi, Z. Ogita, T. Kirakawa, and Y. Mitsui.

1985. Appearance of extrachromosomal circular DNAs during in vivo and
in vitro ageing of mammalian cells. Mech Ageing Dev 29: 89-99.
162.

Cohen, Z., and S. Lavi. 2009. Replication independent formation of

extrachromosomal circular DNA in mammalian cell-free system. PLoS
One 4: e6126.
163.

Cabral, M., X. Cheng, S. Singh, and A. S. Ivessa. 2016. Absence of

Non-histone Protein Complexes at Natural Chromosomal Pause Sites

156

Results in Reduced Replication Pausing in Aging Yeast Cells. Cell reports
17: 1747-1754.
164.

Delabaere, L., H. A. Ertl, D. J. Massey, C. M. Hofley, F. Sohail, E.

J. Bienenstock, H. Sebastian, I. Chiolo, and J. R. LaRocque. 2016. Aging
impairs double-strand break repair by homologous recombination in
Drosophila germ cells. Aging Cell.
165.

Saeki, T., I. Machida, and S. Nakai. 1980. Genetic control of diploid

recovery after gamma-irradiation in the yeast Saccharomyces cerevisiae.
Mutat Res 73: 251-265.
166.

Muris, D. F., K. Vreeken, A. M. Carr, B. C. Broughton, A. R.

Lehmann, P. H. Lohman, and A. Pastink. 1993. Cloning the RAD51
homologue of Schizosaccharomyces pombe. Nucleic Acids Res 21: 45864591.
167.

Sonoda, E., M. S. Sasaki, J. M. Buerstedde, O. Bezzubova, A.

Shinohara, H. Ogawa, M. Takata, Y. Yamaguchi-Iwai, and S. Takeda.
1998. Rad51-deficient vertebrate cells accumulate chromosomal breaks
prior to cell death. Embo J 17: 598-608.
168.

Tsuzuki, T., Y. Fujii, K. Sakumi, Y. Tominaga, K. Nakao, M.

Sekiguchi, A. Matsushiro, Y. Yoshimura, and MoritaT. 1996. Targeted
disruption of the Rad51 gene leads to lethality in embryonic mice. Proc
Natl Acad Sci U S A 93: 6236-6240.

157

169.

Richardson, C., J. M. Stark, M. Ommundsen, and M. Jasin. 2004.

Rad51 overexpression promotes alternative double-strand break repair
pathways and genome instability. Oncogene 23: 546-553.
170.

Paffett, K. S., J. A. Clikeman, S. Palmer, and J. A. Nickoloff. 2005.

Overexpression

of

Rad51

inhibits

double-strand

break-induced

homologous recombination but does not affect gene conversion tract
lengths. DNA Repair (Amst) 4: 687-698.
171.

Klein, H. L. 2008. The consequences of Rad51 overexpression for

normal and tumor cells. DNA Repair (Amst) 7: 686-693.
172.

Bressan, D. A., B. K. Baxter, and J. H. Petrini. 1999. The Mre11-

Rad50-Xrs2 protein complex facilitates homologous recombination-based
double-strand break repair in Saccharomyces cerevisiae. Mol Cell Biol 19:
7681-7687.
173.

Schild, D., and C. Wiese. 2010. Overexpression of RAD51

suppresses recombination defects: a possible mechanism to reverse
genomic instability. Nucleic Acids Res 38: 1061-1070.
174.

Bindra, R. S., P. J. Schaffer, A. Meng, J. Woo, K. Maseide, M. E.

Roth, P. Lizardi, D. W. Hedley, R. G. Bristow, and P. M. Glazer. 2004.
Down-regulation of Rad51 and decreased homologous recombination in
hypoxic cancer cells. Mol Cell Biol 24: 8504-8518.
175.

Raderschall, E., K. Stout, S. Freier, V. Suckow, S. Schweiger, and

T. Haaf. 2002. Elevated levels of Rad51 recombination protein in tumor
cells. Cancer Res 62: 219-225.

158

176.

Yuan, S. S., M. F. Hou, Y. C. Hsieh, C. Y. Huang, Y. C. Lee, Y. J.

Chen, and S. Lo. 2012. Role of MRE11 in cell proliferation, tumor
invasion, and DNA repair in breast cancer. Journal of the National Cancer
Institute 104: 1485-1502.
177.

Van Holde, K. E. 1989. Chromatin. Springer-Verlag, New York.

178.

Ransom, M., B. K. Dennehey, and J. K. Tyler. 2010. Chaperoning

histones during DNA replication and repair. Cell 140: 183-195.
179.

Venkatesh, S., and J. L. Workman. 2015. Histone exchange,

chromatin structure and the regulation of transcription. Nat Rev Mol Cell
Biol 16: 178-189.
180.

Filipescu, D., S. Muller, and G. Almouzni. 2014. Histone H3

variants and their chaperones during development and disease:
contributing to epigenetic control. Annu Rev Cell Dev Biol 30: 615-646.
181.

Neumann, H., S. M. Hancock, R. Buning, A. Routh, L. Chapman, J.

Somers, T. Owen-Hughes, J. van Noort, D. Rhodes, and J. W. Chin. 2009.
A method for genetically installing site-specific acetylation in recombinant
histones defines the effects of H3 K56 acetylation. Molecular cell 36: 153163.
182.

North, J. A., J. C. Shimko, S. Javaid, A. M. Mooney, M. A. Shoffner,

S. D. Rose, R. Bundschuh, R. Fishel, J. J. Ottesen, and M. G. Poirier.
2012. Regulation of the nucleosome unwrapping rate controls DNA
accessibility. Nucleic acids research 40: 10215-10227.

159

183.

Williams, S. K., D. Truong, and J. K. Tyler. 2008. Acetylation in the

globular core of histone H3 on lysine-56 promotes chromatin disassembly
during transcriptional activation. Proc Natl Acad Sci U S A 105: 90009005.
184.

Marzluff, W. F., E. J. Wagner, and R. J. Duronio. 2008. Metabolism

and regulation of canonical histone mRNAs: life without a poly(A) tail.
Nature reviews. Genetics 9: 843-854.
185.

Kouzarides, T. 2007. Chromatin modifications and their function.

Cell 128: 693-705.
186.

Xie, W., C. Song, N. L. Young, A. S. Sperling, F. Xu, R. Sridharan,

A. E. Conway, B. A. Garcia, K. Plath, A. T. Clark, and M. Grunstein. 2009.
Histone h3 lysine 56 acetylation is linked to the core transcriptional
network in human embryonic stem cells. Mol Cell 33: 417-427.
187.

Das, C., M. S. Lucia, K. C. Hansen, and J. K. Tyler. 2009.

CBP/p300-mediated acetylation of histone H3 on lysine 56. Nature 459:
113-117.
188.

Tan, Y., Y. Xue, C. Song, and M. Grunstein. 2013. Acetylated

histone H3K56 interacts with Oct4 to promote mouse embryonic stem cell
pluripotency. Proceedings of the National Academy of Sciences of the
United States of America 110: 11493-11498.
189.

Skalska, L., R. Stojnic, J. Li, B. Fischer, G. Cerda-Moya, H. Sakai,

S. Tajbakhsh, S. Russell, B. Adryan, and S. J. Bray. 2015. Chromatin

160

signatures at Notch-regulated enhancers reveal large-scale changes in
H3K56ac upon activation. The EMBO journal 34: 1889-1904.
190.

Jack, A. P., S. Bussemer, M. Hahn, S. Punzeler, M. Snyder, M.

Wells, G. Csankovszki, I. Solovei, G. Schotta, and S. B. Hake. 2013.
H3K56me3 is a novel, conserved heterochromatic mark that largely but
not completely overlaps with H3K9me3 in both regulation and localization.
PloS one 8: e51765.
191.

Liu, Y., D. L. Wang, S. Chen, L. Zhao, and F. L. Sun. 2012.

Oncogene Ras/phosphatidylinositol 3-kinase signaling targets histone H3
acetylation at lysine 56. The Journal of biological chemistry 287: 4146941480.
192.

Yu, Y., C. Song, Q. Zhang, P. A. DiMaggio, B. A. Garcia, A. York,

M. F. Carey, and M. Grunstein. 2012. Histone H3 lysine 56 methylation
regulates DNA replication through its interaction with PCNA. Mol Cell 46:
7-17.
193.

Gu, B., K. Watanabe, and X. Dai. 2012. Pygo2 regulates histone

gene expression and H3 K56 acetylation in human mammary epithelial
cells. Cell cycle 11: 79-87.
194.

Lo, K. A., M. K. Bauchmann, A. P. Baumann, C. J. Donahue, M. A.

Thiede, L. S. Hayes, S. A. des Etages, and E. Fraenkel. 2011. Genomewide profiling of H3K56 acetylation and transcription factor binding sites in
human adipocytes. PloS one 6: e19778.

161

195.

Saenz Robles, M. T., C. Shivalila, J. Wano, S. Sorrells, A. Roos,

and J. M. Pipas. 2013. Two independent regions of simian virus 40 T
antigen increase CBP/p300 levels, alter patterns of cellular histone
acetylation, and immortalize primary cells. J Virol 87: 13499-13509.
196.

Ura, H., K. Murakami, T. Akagi, K. Kinoshita, S. Yamaguchi, S.

Masui, H. Niwa, H. Koide, and T. Yokota. 2011. Eed/Sox2 regulatory loop
controls ES cell self-renewal through histone methylation and acetylation.
EMBO J 30: 2190-2204.
197.

Dutta, D., S. Ray, P. Home, B. Saha, S. Wang, N. Sheibani, O.

Tawfik, N. Cheng, and S. Paul. 2010. Regulation of angiogenesis by
histone chaperone HIRA-mediated incorporation of lysine 56-acetylated
histone H3.3 at chromatin domains of endothelial genes. J Biol Chem 285:
41567-41577.
198.

Drogaris, P., V. Villeneuve, C. Pomies, E. H. Lee, V. Bourdeau, E.

Bonneil, G. Ferbeyre, A. Verreault, and P. Thibault. 2012. Histone
deacetylase inhibitors globally enhance h3/h4 tail acetylation without
affecting h3 lysine 56 acetylation. Scientific reports 2: 220.
199.

Williams, S. K., D. Truong, and J. K. Tyler. 2008. Acetylation in the

globular core of histone H3 on lysine-56 promotes chromatin disassembly
during transcriptional activation. Proceedings of the National Academy of
Sciences of the United States of America 105: 9000-9005.

162

200.

Yuan, J., M. Pu, Z. Zhang, and Z. Lou. 2009. Histone H3-K56

acetylation is important for genomic stability in mammals. Cell Cycle 8:
1747-1753.
201.

Pal, S., H. Graves, R. Ohsawa, T. H. Huang, P. Wang, L.

Harmacek, and J. Tyler. 2016. The Commercial Antibodies Widely Used to
Measure H3 K56 Acetylation Are Non-Specific in Human and Drosophila
Cells. PLoS One 11: e0155409.
202.

Zhu, Q., A. Battu, A. Ray, G. Wani, J. Qian, J. He, Q. E. Wang, and

A. A. Wani. 2015. Damaged DNA-binding protein down-regulates
epigenetic mark H3K56Ac through histone deacetylase 1 and 2. Mutat
Res 776: 16-23.
203.

Etchegaray, J. P., L. Chavez, Y. Huang, K. N. Ross, J. Choi, B.

Martinez-Pastor, R. M. Walsh, C. A. Sommer, M. Lienhard, A. Gladden, S.
Kugel, D. M. Silberman, S. Ramaswamy, G. Mostoslavsky, K.
Hochedlinger, A. Goren, A. Rao, and R. Mostoslavsky. 2015. The histone
deacetylase SIRT6 controls embryonic stem cell fate via TET-mediated
production of 5-hydroxymethylcytosine. Nat Cell Biol 17: 545-557.
204.

Toiber, D., F. Erdel, K. Bouazoune, D. M. Silberman, L. Zhong, P.

Mulligan, C. Sebastian, C. Cosentino, B. Martinez-Pastor, S. Giacosa, A.
D'Urso, A. M. Naar, R. Kingston, K. Rippe, and R. Mostoslavsky. 2013.
SIRT6 recruits SNF2H to DNA break sites, preventing genomic instability
through chromatin remodeling. Mol Cell 51: 454-468.

163

205.

Liu, J., K. McConnell, M. Dixon, and B. R. Calvi. 2012. Analysis of

model replication origins in Drosophila reveals new aspects of the
chromatin landscape and its relationship to origin activity and the
prereplicative complex. Molecular biology of the cell 23: 200-212.
206.

Kawakami, K., A. Nakamura, and S. Goto. 2012. Dietary restriction

increases site-specific histone H3 acetylation in rat liver: possible
modulation by sirtuins. Biochem Biophys Res Commun 418: 836-840.
207.

Kong, S., S. J. Kim, B. Sandal, S. M. Lee, B. Gao, D. D. Zhang, and

D. Fang. 2011. The type III histone deacetylase Sirt1 protein suppresses
p300-mediated histone H3 lysine 56 acetylation at Bclaf1 promoter to
inhibit T cell activation. J Biol Chem 286: 16967-16975.
208.

Miller, K. M., J. V. Tjeertes, J. Coates, G. Legube, S. E. Polo, S.

Britton, and S. P. Jackson. 2010. Human HDAC1 and HDAC2 function in
the DNA-damage response to promote DNA nonhomologous end-joining.
Nat Struct Mol Biol 17: 1144-1151.
209.

Dovey, O. M., C. T. Foster, and S. M. Cowley. 2010. Histone

deacetylase 1 (HDAC1), but not HDAC2, controls embryonic stem cell
differentiation. Proc Natl Acad Sci U S A 107: 8242-8247.
210.

Michishita, E., R. A. McCord, L. D. Boxer, M. F. Barber, T. Hong, O.

Gozani, and K. F. Chua. 2009. Cell cycle-dependent deacetylation of
telomeric histone H3 lysine K56 by human SIRT6. Cell Cycle 8: 26642666.

164

211.

Stejskal, S., K. Stepka, L. Tesarova, K. Stejskal, M. Matejkova, P.

Simara, Z. Zdrahal, and I. Koutna. 2015. Cell cycle-dependent changes in
H3K56ac in human cells. Cell Cycle 14: 3851-3863.
212.

Maroschik, B., A. Gurtler, A. Kramer, U. Rossler, M. Gomolka, S.

Hornhardt, S. Mortl, and A. A. Friedl. 2014. Radiation-induced alterations
of histone post-translational modification levels in lymphoblastoid cell
lines. Radiat Oncol 9: 15.
213.

Li, B., T. Su, R. Ferrari, J. Y. Li, and S. K. Kurdistani. 2014. A

unique epigenetic signature is associated with active DNA replication loci
in human embryonic stem cells. Epigenetics : official journal of the DNA
Methylation Society 9: 257-267.
214.

Chen, H., M. Fan, L. M. Pfeffer, and R. N. Laribee. 2012. The

histone H3 lysine 56 acetylation pathway is regulated by target of
rapamycin (TOR) signaling and functions directly in ribosomal RNA
biogenesis. Nucleic Acids Res 40: 6534-6546.
215.

Vempati, R. K., and D. Haldar. 2012. DNA damage in the presence

of chemical genotoxic agents induce acetylation of H3K56 and H4K16 but
not H3K9 in mammalian cells. Mol Biol Rep 39: 303-308.
216.

Battu, A., A. Ray, and A. A. Wani. 2011. ASF1A and ATM regulate

H3K56-mediated cell-cycle checkpoint recovery in response to UV
irradiation. Nucleic Acids Res 39: 7931-7945.
217.

Vempati, R. K., R. S. Jayani, D. Notani, A. Sengupta, S. Galande,

and D. Haldar. 2010. p300-mediated acetylation of histone H3 lysine 56

165

functions in DNA damage response in mammals. J Biol Chem 285: 2855328564.
218.

Tjeertes, J. V., K. M. Miller, and S. P. Jackson. 2009. Screen for

DNA-damage-responsive histone modifications identifies H3K9Ac and
H3K56Ac in human cells. EMBO J 28: 1878-1889.

166

Vita

Sangita Pal was born in Berhampore, West Bengal, India on September
27th, 1983, the younger daughter of Dr. Ranjan Kumar Pal and Mrs. Puspa Pal.
After graduating from Barasat Girls’ High School in Barasat, West Bengal in
2002, she attended West Bengal University of Animal and Fishery Sciences in
Kolkata, India and received her Bachelor’s degree in Veterinary Medicine in
2007. In January of 2008, she started to pursue her Master’s degree with a major
in Biological Sciences at The University of Texas at El Paso, El Paso, Texas and
earned her Master’s degree in 2010. In 2010 fall, she entered The University of
Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical
Sciences to pursue her doctoral studies majoring in Biomedical Sciences. A year
later in 2011, she joined the Genes and Development graduate program and
performed her dissertation research under the guidance of Dr. Jessica Tyler.

Permanent address:
57/16, Sitalatala Road,
Barasat, West Bengal, India, 700124.

167

